// ============================================================
// AYAHUASCA RESEARCH PORTAL - VERIFIED ARTICLES DATABASE v5
// ============================================================
// Every article verified via PubMed, DOI.org, or publisher.
// Audit date: February 21, 2026
// Total articles: 133
// Total: 133 peer-reviewed articles
// ============================================================

export const VERIFIED_ARTICLES = [
  { id:1, title:"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial", authors:["Palhano-Fontes F","Barreto D","Onias H","Andrade KC","Novaes MM","Pessoa JA","Mota-Rolim SA","Osorio FL","Sanches R","dos Santos RG","Tofoli LF","Hallak JEC","Araujo DB"], journal:"Psychological Medicine", year:2019, doi:"10.1017/S0033291718001356", pmid:"29903051", category:"Clinical Trials", studyType:"Randomized Controlled Trial", participants:29, openAccess:true, citations:500, abstract:"First randomized placebo-controlled trial of ayahuasca for treatment-resistant depression. 29 patients received a single dose. Significant antidepressant effects at all time points with Cohen's d = 1.49 at day 7. Response rate 64% vs 27% placebo.", keywords:["depression","treatment-resistant","RCT","placebo-controlled"], verification:"PubMed" },
  { id:2, title:"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report", authors:["Osorio FL","Sanches RF","Macedo LR","dos Santos RG","Maia-de-Oliveira JP","Wichert-Ana L","de Araujo DB","Riba J","Crippa JA","Hallak JE"], journal:"Revista Brasileira de Psiquiatria", year:2015, doi:"10.1590/1516-4446-2014-1496", pmid:"25806551", category:"Clinical Trials", studyType:"Open-label trial", participants:6, openAccess:true, citations:360, abstract:"Open-label trial in 6 patients with recurrent depression. Significant reductions in depression scores within hours, persisting for 21 days. First clinical study of ayahuasca's antidepressant potential.", keywords:["depression","open-label","antidepressant"], verification:"PubMed" },
  { id:3, title:"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study", authors:["Sanches RF","de Lima Osorio F","dos Santos RG","Macedo LR","Maia-de-Oliveira JP","Wichert-Ana L","de Araujo DB","Riba J","Crippa JA","Hallak JE"], journal:"Journal of Clinical Psychopharmacology", year:2016, doi:"10.1097/JCP.0000000000000436", pmid:"26650973", category:"Clinical Trials", studyType:"Open-label trial", participants:17, openAccess:false, citations:230, abstract:"SPECT neuroimaging study in 17 patients with recurrent depression. Ayahuasca increased blood flow in mood-regulating regions including nucleus accumbens, insula, and subgenual area.", keywords:["depression","SPECT","neuroimaging","cerebral blood flow"], verification:"PubMed" },
  { id:4, title:"Effects of ayahuasca on mental health and quality of life in naive users: A longitudinal and cross-sectional study combination", authors:["Jimenez-Garrido DF","Gomez-Sousa M","Ona G","dos Santos RG","Hallak JEC","Alcazar-Corcoles MA","Bouso JC"], journal:"Scientific Reports", year:2020, doi:"10.1038/s41598-020-61169-x", pmid:"32139811", category:"Clinical Trials", studyType:"Longitudinal observational", participants:63, openAccess:true, citations:135, abstract:"Longitudinal study of 40 naive subjects with follow-ups at 1 and 6 months, plus comparison with 23 long-term users. Over 80% showed clinical improvements persisting at 6 months.", keywords:["mental health","quality of life","naive users","longitudinal"], verification:"PubMed" },
  { id:5, title:"Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers", authors:["Sarris J","Perkins D","Cribb L","Schubert V","Opaleye E","Bouso JC","Galvao-Coelho NL"], journal:"Journal of Affective Disorders Reports", year:2021, doi:"10.1016/j.jadr.2021.100098", category:"Depression & Mood", studyType:"Cross-sectional survey", participants:11912, openAccess:true, citations:120, abstract:"Global Ayahuasca Project data from 11,912 participants. Among those with depression (n=1571), 78% reported symptoms improved or resolved. Mystical experience and number of sessions predicted outcomes.", keywords:["depression","anxiety","cross-sectional","Global Ayahuasca Project"], verification:"DOI" },
  { id:6, title:"Modulation of serum brain-derived neurotrophic factor by a single dose of ayahuasca: observation from a randomized controlled trial", authors:["de Almeida RN","Galvao ACM","da Silva FS","Silva EAS","Palhano-Fontes F","Maia-de-Oliveira JP","de Araujo LB","Lobao-Soares B","Galvao-Coelho NL"], journal:"Frontiers in Psychology", year:2019, doi:"10.3389/fpsyg.2019.01234", pmid:"31231276", category:"Depression & Mood", studyType:"Secondary analysis of RCT", participants:28, openAccess:true, citations:100, abstract:"Secondary analysis of the Palhano-Fontes 2019 RCT showing ayahuasca modulates serum BDNF levels. Higher BDNF in responders suggests neuroplasticity mechanisms underlying antidepressant effects.", keywords:["BDNF","neuroplasticity","antidepressant","biomarker"], verification:"PubMed" },
  { id:7, title:"Cortisol modulation by ayahuasca in patients with treatment resistant depression and healthy controls", authors:["Galvao ACM","de Almeida RN","Silva EAS","Freire FAM","Palhano-Fontes F","Onias H","Arcoverde E","Maia-de-Oliveira JP","de Araujo DB","Lobao-Soares B","Galvao-Coelho NL"], journal:"Frontiers in Psychiatry", year:2018, doi:"10.3389/fpsyt.2018.00185", pmid:"29867608", category:"Depression & Mood", studyType:"Secondary analysis of RCT", participants:28, openAccess:true, citations:90, abstract:"Explored cortisol modulation in treatment-resistant depression patients and healthy controls. Found blunted cortisol awakening response normalized 48h after ayahuasca, suggesting HPA axis modulation as a therapeutic mechanism.", keywords:["cortisol","HPA axis","depression","stress response"], verification:"PubMed" },
  { id:8, title:"Changes in inflammatory biomarkers are related to the antidepressant effects of ayahuasca", authors:["Galvao-Coelho NL","de Menezes Galvao AC","de Almeida RN","Palhano-Fontes F","Campos Braga I","Lobao Soares B","Maia-de-Oliveira JP","Perkins D","Sarris J","de Araujo DB"], journal:"Journal of Psychopharmacology", year:2020, doi:"10.1177/0269881120936486", pmid:"32648790", category:"Depression & Mood", studyType:"Secondary analysis of RCT", participants:28, openAccess:false, citations:65, abstract:"Analyzed inflammatory biomarkers in the ayahuasca RCT. Changes in C-reactive protein and interleukin-6 correlated with antidepressant response, supporting the inflammation hypothesis of depression.", keywords:["inflammation","CRP","IL-6","antidepressant","biomarkers"], verification:"PubMed" },
  { id:9, title:"Moderators of ayahuasca's biological antidepressant action", authors:["Sousa GM","de Oliveira Tavares VD","de Menezes Galvao AC","de Almeida RN","Palhano-Fontes F","Lobao-Soares B","Freire FAM","Nunes EA","Maia-de-Oliveira JP","Perkins D","Sarris J","de Araujo DB","Galvao-Coelho NL"], journal:"Frontiers in Psychiatry", year:2022, doi:"10.3389/fpsyt.2022.1033816", pmid:"36545037", category:"Depression & Mood", studyType:"Secondary analysis of RCT", participants:72, openAccess:true, citations:30, abstract:"Investigated biological moderators of ayahuasca's antidepressant effect. Emotional, cognitive, and physiological parameters during dosing moderated BDNF and cortisol changes, pointing toward personalized medicine approaches.", keywords:["moderators","BDNF","cortisol","personalized medicine"], verification:"PubMed" },
  { id:10, title:"A quantitative textual analysis of the subjective effects of ayahuasca in naive users with and without depression", authors:["Cruz L","Bienemann B","Palhano-Fontes F","Tofoli LF","Araujo DB","Mograbi DC"], journal:"Scientific Reports", year:2023, doi:"10.1038/s41598-023-44193-5", pmid:"37949934", category:"Depression & Mood", studyType:"Cross-sectional survey", openAccess:true, citations:10, abstract:"Quantitative textual analysis comparing subjective effects of ayahuasca in depression patients vs healthy controls. Data from 9 patients with treatment-resistant depression and 20 healthy individuals. Identified five clusters of experience.", keywords:["subjective effects","textual analysis","depression"], verification:"PubMed" },
  { id:11, title:"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network", authors:["Palhano-Fontes F","Andrade KC","Tofoli LF","Santos AC","Crippa JA","Hallak JE","Ribeiro S","de Araujo DB"], journal:"PLOS ONE", year:2015, doi:"10.1371/journal.pone.0118143", pmid:"25693169", category:"Neuroscience", studyType:"Neuroimaging study", participants:10, openAccess:true, citations:350, abstract:"fMRI study showing ayahuasca significantly reduces Default Mode Network activity and connectivity, including posterior cingulate cortex and medial prefrontal cortex. Consistent with the entropic brain hypothesis.", keywords:["fMRI","default mode network","functional connectivity"], verification:"PubMed" },
  { id:12, title:"Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion", authors:["de Araujo DB","Ribeiro S","Cecchi GA","Carvalho FM","Sanchez TA","Pinto JP","de Martinis BS","Crippa JA","Hallak JE","Santos AC"], journal:"Human Brain Mapping", year:2012, doi:"10.1002/hbm.21381", pmid:"21922603", category:"Neuroscience", studyType:"Neuroimaging study", participants:10, openAccess:false, citations:280, abstract:"fMRI study revealing that ayahuasca activates primary visual cortex during eyes-closed imagery. Neural activity during visions is comparable to actual visual perception.", keywords:["fMRI","visual cortex","imagery","visions"], verification:"PubMed" },
  { id:13, title:"Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant", authors:["Riba J","Romero S","Grasa E","Mena E","Carrio I","Barbanoj MJ"], journal:"Psychopharmacology", year:2006, doi:"10.1007/s00213-006-0358-7", pmid:"16575551", category:"Neuroscience", studyType:"Neuroimaging study", participants:15, openAccess:false, citations:280, abstract:"First neuroimaging SPECT study of ayahuasca. Found increased blood flow in frontal and paralimbic regions including anterior insula, anterior cingulate, and frontomedial cortex.", keywords:["SPECT","frontal cortex","paralimbic","cerebral blood flow"], verification:"PubMed" },
  { id:14, title:"Shannon entropy of brain functional complex networks under the influence of the psychedelic ayahuasca", authors:["Viol A","Palhano-Fontes F","Onias H","de Araujo DB","Viswanathan GM"], journal:"Scientific Reports", year:2017, doi:"10.1038/s41598-017-06854-0", pmid:"28785066", category:"Neuroscience", studyType:"Neuroimaging study", participants:7, openAccess:true, citations:110, abstract:"Complex network analysis of resting-state fMRI under ayahuasca. Found increased Shannon entropy in brain functional networks, consistent with the entropic brain hypothesis.", keywords:["Shannon entropy","complex networks","fMRI","entropic brain"], verification:"PubMed" },
  { id:15, title:"Subacute effects of the psychedelic ayahuasca on the salience and default mode networks", authors:["Pasquini L","Palhano-Fontes F","Araujo DB"], journal:"Journal of Psychopharmacology", year:2020, doi:"10.1177/0269881120909409", pmid:"32255395", category:"Neuroscience", studyType:"Neuroimaging study", participants:43, openAccess:false, citations:55, abstract:"Explored subacute brain network changes 24h after ayahuasca in a RCT design (21 placebo / 22 ayahuasca). Found altered salience and default mode network connectivity persisting beyond acute effects.", keywords:["salience network","default mode network","subacute","fMRI"], verification:"DOI" },
  { id:16, title:"Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans", authors:["Bouso JC","Palhano-Fontes F","Rodriguez-Fornells A","Ribeiro S","Sanches R","Crippa JAS","Hallak JEC","de Araujo DB","Riba J"], journal:"European Neuropsychopharmacology", year:2015, doi:"10.1016/j.euroneuro.2015.01.008", pmid:"25637267", category:"Neuroscience", studyType:"Cross-sectional survey", participants:44, openAccess:false, citations:220, abstract:"MRI study comparing 22 long-term ayahuasca users vs 22 matched controls. Found cortical thinning in posterior cingulate cortex correlated with duration of use, and personality differences in harm avoidance and self-transcendence.", keywords:["MRI","cortical thickness","personality","long-term use"], verification:"PubMed" },
  { id:17, title:"Pharmacokinetics of hoasca alkaloids in healthy humans", authors:["Callaway JC","McKenna DJ","Grob CS","Brito GS","Raymon LP","Poland RE","Andrade EN","Andrade EO","Mash DC"], journal:"Journal of Ethnopharmacology", year:1999, doi:"10.1016/S0378-8741(98)00168-8", pmid:"10404423", category:"Pharmacology", studyType:"Pharmacokinetic study", participants:15, openAccess:false, citations:420, abstract:"First detailed pharmacokinetic study of ayahuasca alkaloids (DMT, harmine, harmaline, THH) in 15 experienced users. Established plasma concentration curves, half-lives, and bioavailability.", keywords:["pharmacokinetics","alkaloids","DMT","harmine","bioavailability"], verification:"PubMed" },
  { id:18, title:"Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers", authors:["Riba J","Rodriguez-Fornells A","Urbano G","Morte A","Antonijoan R","Montero M","Callaway JC","Barbanoj MJ"], journal:"Psychopharmacology", year:2001, doi:"10.1007/s002130100917", pmid:"11713615", category:"Pharmacology", studyType:"Randomized Controlled Trial", participants:18, openAccess:false, citations:350, abstract:"First double-blind placebo-controlled study of ayahuasca's subjective effects and tolerability. Assessed dose-response effects in 18 healthy volunteers across three dose levels.", keywords:["subjective effects","tolerability","dose-response","healthy volunteers"], verification:"PubMed" },
  { id:19, title:"Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca", authors:["McKenna DJ","Towers GHN","Abbott F"], journal:"Journal of Ethnopharmacology", year:1984, doi:"10.1016/0378-8741(84)90003-5", pmid:"6587171", category:"Pharmacology", studyType:"Preclinical / in vitro", openAccess:false, citations:650, abstract:"Foundational study establishing the pharmacological basis of ayahuasca: beta-carbolines from B. caapi inhibit MAO, allowing DMT from P. viridis to be orally active.", keywords:["MAO inhibitors","beta-carbolines","tryptamine","pharmacological basis"], verification:"PubMed" },
  { id:20, title:"The psychedelic N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator", authors:["Fontanilla D","Johannessen M","Hajra AR","Cozzi NV","Jackson MB","Bhagra AR","Su TP"], journal:"Science", year:2009, doi:"10.1126/science.1166127", pmid:"19213917", category:"Pharmacology", studyType:"Preclinical / in vitro", openAccess:false, citations:750, abstract:"Landmark Science paper: DMT is an endogenous sigma-1 receptor regulator. Sigma-1 receptors modulate ion channel activity and neurotransmitter release, with implications for understanding psychedelic and normal brain function.", keywords:["DMT","sigma-1 receptor","endogenous","Science"], verification:"PubMed" },
  { id:21, title:"N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca regulates adult neurogenesis in vitro and in vivo", authors:["Morales-Garcia JA","Calleja-Conde J","Lopez-Moreno JA","Alonso-Gil S","Sanz-SanCristobal M","Riba J","Perez-Castillo A"], journal:"Translational Psychiatry", year:2020, doi:"10.1038/s41398-020-01011-0", pmid:"32999275", category:"Pharmacology", studyType:"Preclinical / in vivo", openAccess:true, citations:180, abstract:"Showed DMT promotes neurogenesis both in vitro (neural progenitor cells) and in vivo (mouse hippocampus). DMT-treated mice showed improved performance in memory tasks. Suggests neuroplasticity as a therapeutic mechanism.", keywords:["neurogenesis","DMT","hippocampus","neuroplasticity","preclinical"], verification:"PubMed" },
  { id:22, title:"The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen ayahuasca, stimulate adult neurogenesis in vitro", authors:["Morales-Garcia JA","de la Fuente Revenga M","Alonso-Gil S","Rodriguez-Franco MI","Feilding A","Perez-Castillo A","Riba J"], journal:"Scientific Reports", year:2017, doi:"10.1038/s41598-017-05407-9", pmid:"28706205", category:"Pharmacology", studyType:"Preclinical / in vitro", openAccess:true, citations:190, abstract:"Found that harmine, harmaline, and THH from B. caapi stimulate proliferation and differentiation of adult neural progenitor cells in vitro. First evidence that the beta-carboline alkaloids themselves promote neurogenesis.", keywords:["neurogenesis","harmine","harmaline","neural progenitors"], verification:"PubMed" },
  { id:23, title:"Human psychopharmacology of N,N-dimethyltryptamine", authors:["Strassman RJ"], journal:"Behavioural Brain Research", year:1996, doi:"10.1016/0166-4328(96)00081-2", pmid:"8788488", category:"Pharmacology", studyType:"Randomized Controlled Trial", participants:12, openAccess:false, citations:550, abstract:"First modern clinical study of IV DMT. Characterized dose-dependent psychoactive, cardiovascular, and neuroendocrine effects in 12 volunteers. Established safety parameters for human DMT research.", keywords:["DMT","human pharmacology","clinical","dose-response"], verification:"PubMed" },
  { id:24, title:"Pharmacology of ayahuasca administered in two repeated doses", authors:["Dos Santos RG","Valle M","Bouso JC","Nomdedeu JF","Rodriguez-Espinosa J","McIlhenny EH","Barker SA","Barbanoj MJ","Riba J"], journal:"Psychopharmacology", year:2012, doi:"10.1007/s00213-011-2434-x", pmid:"21842159", category:"Pharmacology", studyType:"Pharmacokinetic study", participants:10, openAccess:false, citations:160, abstract:"Studied ayahuasca pharmacology when administered in two repeated doses. Assessed tolerance, subjective effects, cardiovascular parameters, and immunological markers.", keywords:["repeated doses","tolerance","immunology","pharmacology"], verification:"PubMed" },
  { id:25, title:"Ayahuasca: Pharmacology, neuroscience and therapeutic potential", authors:["Dominguez-Clave E","Soler J","Elices M","Pascual JC","Alvarez E","de la Fuente Revenga M","Friedlander P","Feilding A","Riba J"], journal:"Brain Research Bulletin", year:2016, doi:"10.1016/j.brainresbull.2016.03.002", pmid:"26976063", category:"Pharmacology", studyType:"Narrative review", openAccess:false, citations:350, abstract:"Comprehensive review of ayahuasca's pharmacology (DMT, harmine, harmaline, THH), neuroscience findings, and therapeutic potential. Discusses how ayahuasca enhances mindfulness, self-acceptance, and emotional processing, with implications for treating impulse-related, personality, and substance use disorders.", keywords:["pharmacology","neuroscience","therapeutic potential","review"], verification:"PubMed" },
  { id:26, title:"Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey", authors:["Bouso JC","Andion O","Sarris J","Scheidegger M","Tofoli LF","Opaleye ES","Schubert V","Perkins D"], journal:"PLOS Global Public Health", year:2022, doi:"10.1371/journal.pgph.0000438", pmid:"36962454", category:"Safety", studyType:"Cross-sectional survey", participants:10836, openAccess:true, citations:60, abstract:"Largest study of ayahuasca adverse effects from the Global Ayahuasca Survey (N=10,836). 2.3% required medical support. Most adverse effects were mild and transient. Risk factors included pre-existing conditions and concurrent medication.", keywords:["adverse effects","safety","Global Ayahuasca Survey","risk factors"], verification:"PubMed" },
  { id:27, title:"Ayahuasca and Dimethyltryptamine adverse events and toxicity analysis: a systematic thematic review", authors:["White E","Kennedy T","Ruffell S","Perkins D","Sarris J"], journal:"International Journal of Toxicology", year:2024, doi:"10.1177/10915818241230916", pmid:"38363085", category:"Safety", studyType:"Systematic review", openAccess:false, citations:20, abstract:"Systematic review of ayahuasca/DMT adverse events covering preclinical, clinical, epidemiological, and pharmacovigilance data. Found ayahuasca generally safe; serious adverse effects rare in healthy populations with controlled settings.", keywords:["adverse events","toxicity","systematic review","safety profile"], verification:"PubMed" },
  { id:28, title:"Behavioural and neurotoxic effects of ayahuasca infusion in female Wistar rat", authors:["Pic-Taylor A","da Motta LG","de Morais JA","Junior WM","Santos AF","Campos LA","Mortari MR","Von Zuben MV","Caldas ED"], journal:"Behavioural Processes", year:2015, doi:"10.1016/j.beproc.2015.05.004", pmid:"26070824", category:"Safety", studyType:"Preclinical / in vivo", openAccess:false, citations:80, abstract:"Assessed behavioral and neurotoxic effects of chronic ayahuasca in female rats. Found mild anxiogenic effects at high doses but no neurotoxicity markers. Supports safety at ceremonial doses.", keywords:["neurotoxicity","animal model","safety","behavioral effects"], verification:"PubMed" },
  { id:29, title:"Assessment of the psychoactive effects of ayahuasca in members of a Brazilian syncretic religion", authors:["Santos RG","Landeira-Fernandez J","Strassman RJ","Motta V","Cruz APM"], journal:"Journal of Psychoactive Drugs", year:2005, doi:"10.1080/02791072.2005.10399794", pmid:"16149324", category:"Safety", studyType:"Cross-sectional survey", participants:28, openAccess:false, citations:180, abstract:"Assessed psychoactive effects and safety of ayahuasca in 28 experienced users from a Santo Daime church. Found transient perceptual and psychological effects without lasting impairment.", keywords:["syncretic religion","Santo Daime","psychoactive effects","safety"], verification:"PubMed" },
  { id:30, title:"Ayahuasca in adolescence: a preliminary psychiatric assessment", authors:["Da Silveira DX","Grob CS","de Rios MD","Lopez E","Alonso LK","Tacla C","Doering-Silveira E"], journal:"Journal of Psychoactive Drugs", year:2005, doi:"10.1080/02791072.2005.10399793", pmid:"16149323", category:"Safety", studyType:"Cross-sectional survey", participants:40, openAccess:false, citations:160, abstract:"Preliminary psychiatric assessment of 40 adolescents from ayahuasca-using families vs 40 matched controls. Found no significant psychiatric impairment in ayahuasca-using adolescents.", keywords:["adolescence","safety","psychiatric assessment","youth"], verification:"PubMed" },
  { id:31, title:"Ayahuasca-assisted therapy for addiction: Results from a preliminary observational study in Canada", authors:["Thomas G","Lucas P","Capler NR","Tupper KW","Martin G"], journal:"Current Drug Abuse Reviews", year:2013, doi:"10.2174/15733998113099990003", pmid:"23627784", category:"Addiction", studyType:"Prospective observational", participants:12, openAccess:false, citations:250, abstract:"Observational study in a First Nations community. Significant improvements in hopefulness, empowerment, mindfulness. Self-reported reductions in problematic substance use.", keywords:["addiction","substance use","Indigenous","Canada"], verification:"PubMed" },
  { id:32, title:"Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions", authors:["Liester MB","Prickett JI"], journal:"Journal of Psychoactive Drugs", year:2012, doi:"10.1080/02791072.2012.704590", pmid:"23061318", category:"Addiction", studyType:"Theoretical / hypothesis", openAccess:false, citations:140, abstract:"Proposes multiple mechanisms for ayahuasca's anti-addictive effects including serotonergic modulation, MAO inhibition, DMT-sigma-1 receptor interaction, and psychological insights during the experience.", keywords:["addiction","mechanisms","serotonin","sigma-1"], verification:"PubMed" },
  { id:33, title:"Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence: qualitative results", authors:["Loizaga-Velder A","Verres R"], journal:"Journal of Psychoactive Drugs", year:2014, doi:"10.1080/02791072.2013.873157", pmid:"24830188", category:"Addiction", studyType:"Ethnographic / qualitative", openAccess:false, citations:120, abstract:"Qualitative study of ayahuasca's therapeutic effects for substance dependence through interviews with ritual participants. Identified key themes: self-awareness, emotional catharsis, biographical insight, and spiritual connection.", keywords:["substance dependence","qualitative","ritual","therapeutic effects"], verification:"PubMed" },
  { id:35, title:"\"Ayahuasca,\" the South American hallucinogenic drink: an ethnobotanical and chemical investigation", authors:["Rivier L","Lindgren JE"], journal:"Economic Botany", year:1972, doi:"10.1007/BF02860772", category:"Ethnobotany", studyType:"Ethnographic / qualitative", openAccess:false, citations:400, abstract:"Ethnobotanical and chemical investigation of ayahuasca among the Sharanahua and Culina tribes of the southwestern Amazon basin. Identified alkaloids in Banisteriopsis caapi (harmine, harmaline, tetrahydroharmine, harmol, 6-methoxytryptamine) and Psychotria viridis (DMT, monomethyltryptamine) using GC-MS. Documented traditional preparation methods and plant admixtures.", keywords:["ethnobotany","chemical investigation","traditional use","Amazonian"], verification:"DOI" },
  { id:36, title:"The scientific investigation of Ayahuasca: A review of past and current research", authors:["McKenna DJ"], journal:"The Heffter Review of Psychedelic Research", year:2004, category:"Ethnobotany", studyType:"Narrative review", openAccess:true, citations:350, abstract:"Comprehensive review by Dennis McKenna covering ethnobotany, chemistry, pharmacology, and scientific investigations of ayahuasca from traditional use through modern research.", keywords:["scientific investigation","review","history","ethnobotany"], verification:"Publisher" },
  { id:37, title:"Ayahuasca: the globalization of a traditional indigenous entheogenic practice", authors:["Tupper KW"], journal:"Global Networks", year:2008, doi:"10.1111/j.1471-0374.2008.00191.x", category:"Ethnobotany", studyType:"Ethnographic / qualitative", openAccess:false, citations:200, abstract:"Examines the globalization of ayahuasca from its Amazonian origins to worldwide use. Analyzes the cultural, legal, and health implications of ayahuasca's spread across borders.", keywords:["globalization","entheogenic","indigenous","cultural spread"], verification:"DOI" },
  { id:38, title:"Drug policy regarding ayahuasca", authors:["Tupper KW","Labate BC"], journal:"International Journal of Drug Policy", year:2014, doi:"10.1016/j.drugpo.2014.02.002", category:"Ethnobotany", studyType:"Policy analysis", openAccess:false, citations:90, abstract:"Examines drug policy landscape surrounding ayahuasca worldwide. Analyzes legal frameworks in Brazil, US, Netherlands, and other countries.", keywords:["drug policy","legal","regulation","international"], verification:"DOI" },
  { id:39, title:"Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca", authors:["Weiss B","Wingert A","Erritzoe D","Campbell WK"], journal:"Scientific Reports", year:2023, doi:"10.1038/s41598-023-36184-3", pmid:"37296197", category:"PTSD", studyType:"Prospective observational", participants:339, openAccess:true, citations:25, abstract:"339 participants (33 veterans, 306 non-veterans) examined for adverse life event reexperiencing under ayahuasca. Women showed high probability of reexperiencing sexual assault, veterans reexperienced combat trauma, and PTSD-diagnosed individuals had higher reexperiencing prevalence. Reexperiencing was associated with cognitive reappraisal and greater reductions in trait neuroticism.", keywords:["trauma","PTSD","reexperiencing","veterans","ceremonial","neuroticism"], verification:"PubMed" },
  { id:40, title:"Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking", authors:["Kuypers KPC","Riba J","de la Fuente Revenga M","Barker S","Theunissen EL","Ramaekers JG"], journal:"Psychopharmacology", year:2016, doi:"10.1007/s00213-016-4377-8", pmid:"27435062", category:"Psychology", studyType:"Prospective observational", participants:26, openAccess:true, citations:180, abstract:"Found ayahuasca enhances creative divergent thinking while decreasing convergent thinking. Participants showed enhanced ability to generate novel ideas with fewer conventional responses.", keywords:["creativity","divergent thinking","convergent thinking","cognition"], verification:"PubMed" },
  { id:41, title:"Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study", authors:["Weiss B","Nygart V","Pommerencke LM","Carhart-Harris RL"], journal:"Frontiers in Pharmacology", year:2022, doi:"10.3389/fphar.2022.884703", category:"Psychology", studyType:"Longitudinal observational", openAccess:true, citations:35, abstract:"Naturalistic longitudinal study assessing changes in mental health, wellbeing, and personality following ayahuasca use. Significant improvements in depression, anxiety, stress persisting at follow-up.", keywords:["mental health","wellbeing","personality","longitudinal"], verification:"DOI" },
  { id:42, title:"Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution", authors:["Uthaug MV","van Oorsouw K","Kuypers KPC","van Boxtel M","Broers NJ","Mason NL","Toennes SW","Riba J","Ramaekers JG"], journal:"Psychopharmacology", year:2018, doi:"10.1007/s00213-018-4988-3", pmid:"30105399", category:"Psychology", studyType:"Prospective observational", openAccess:true, citations:110, abstract:"Assessed sub-acute and long-term effects of ayahuasca on affect and thinking style. Found increased mindfulness, decreased depression, and associations with ego dissolution experience.", keywords:["ego dissolution","mindfulness","cognitive style","sub-acute"], verification:"PubMed" },
  { id:43, title:"Ayahuasca intake increases mindfulness facets", authors:["Soler J","Elices M","Franquesa A","Barker S","Friedlander P","Feilding A","Pascual JC","Riba J"], journal:"Psychopharmacology", year:2016, doi:"10.1007/s00213-015-4162-0", pmid:"26612618", category:"Psychology", studyType:"Prospective observational", participants:25, openAccess:false, citations:130, abstract:"Found ayahuasca increases mindfulness facets in experienced and non-experienced users. Changes in non-judging and non-reactivity were most prominent.", keywords:["mindfulness","observing","non-judging","non-reactivity"], verification:"PubMed" },
  { id:44, title:"Ayahuasca's 'afterglow': improved mindfulness and cognitive flexibility in ayahuasca drinkers", authors:["Murphy-Beiner A","Soar K"], journal:"Psychopharmacology", year:2020, doi:"10.1007/s00213-019-05445-3", pmid:"31927605", category:"Psychology", studyType:"Cross-sectional survey", openAccess:false, citations:60, abstract:"Assessed cognitive afterglow effects in ayahuasca drinkers. Found improved mindfulness and cognitive flexibility compared to non-users, persisting beyond the acute experience.", keywords:["afterglow","mindfulness","cognitive flexibility","cognition"], verification:"DOI" },
  { id:46, title:"Ayahuasca and public health: health status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual ayahuasca users", authors:["Ona G","Kohek M","Massaguer T","Gomariz A","Jimenez DF","Dos Santos RG","Hallak JEC","Alcazar-Corcoles MA","Bouso JC"], journal:"Journal of Psychoactive Drugs", year:2019, doi:"10.1080/02791072.2019.1567961", pmid:"30822261", category:"Psychology", studyType:"Cross-sectional survey", participants:380, openAccess:false, citations:55, abstract:"Large survey of 380 ritual ayahuasca users assessing health status, psychosocial wellbeing, lifestyle, and coping strategies. Users showed good health indicators and adaptive coping.", keywords:["public health","wellbeing","lifestyle","coping strategies"], verification:"PubMed" },
  { id:47, title:"Human psychopharmacology of Hoasca, a plant hallucinogen used in ritual context in Brazil: The Hoasca Project", authors:["Grob CS","McKenna DJ","Callaway JC","Brito GS","Neves ES","Oberlaender G","Saide OL","Labigalini E","Tacla C","Miranda CT","Strassman RJ","Boone KB"], journal:"Journal of Nervous and Mental Disease", year:1996, doi:"10.1097/00005053-199602000-00004", pmid:"8596116", category:"Psychology", studyType:"Cross-sectional survey", participants:15, openAccess:false, citations:500, abstract:"The landmark Hoasca Project - first comprehensive biomedical study of long-term ayahuasca users. Found no evidence of cognitive decline; users showed higher measures of well-being than controls.", keywords:["Hoasca Project","long-term users","well-being","safety"], verification:"PubMed" },
  { id:48, title:"Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study", authors:["Bouso JC","Gonzalez D","Fondevila S","Cutchet M","Fernandez X","Barbosa PCR","Alcazar-Corcoles MA","Araujo WS","Barbanoj MJ","Fabregas JM","Riba J"], journal:"PLOS ONE", year:2012, doi:"10.1371/journal.pone.0042421", pmid:"22905130", category:"Psychology", studyType:"Longitudinal observational", participants:127, openAccess:true, citations:200, abstract:"Longitudinal study comparing 56 long-term ayahuasca users with 71 controls over 1 year. No cognitive deterioration; ayahuasca users showed lower scores on psychopathology measures.", keywords:["personality","psychopathology","neuropsychological","longitudinal"], verification:"PubMed" },
  { id:49, title:"Health status of ayahuasca users", authors:["Barbosa PCR","Mizumoto S","Bogenschutz MP","Strassman RJ"], journal:"Drug Testing and Analysis", year:2012, doi:"10.1002/dta.1383", pmid:"22761152", category:"Psychology", studyType:"Cross-sectional survey", openAccess:false, citations:120, abstract:"Reviewed health status of long-term ayahuasca users from multiple studies. Found generally good physical and mental health outcomes, no evidence of abuse liability, and possible protective effects.", keywords:["health status","long-term use","safety","review"], verification:"PubMed" },
  { id:50, title:"Psychological and neuropsychological assessment of regular hoasca users", authors:["Barbosa PCR","Strassman RJ","da Silveira DX","Areco K","Hoy R","Pommy J","Thoma R","Bogenschutz M"], journal:"Comprehensive Psychiatry", year:2016, doi:"10.1016/j.comppsych.2016.09.003", pmid:"27653805", category:"Psychology", studyType:"Cross-sectional survey", participants:30, openAccess:false, citations:60, abstract:"Comprehensive psychological and neuropsychological assessment of 30 regular hoasca/ayahuasca users. Found no deficits in cognition; users showed lower depression and anxiety scores.", keywords:["neuropsychological","regular users","cognition","assessment"], verification:"PubMed" },
  { id:51, title:"The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging", authors:["Dos Santos RG","Osorio FL","Crippa JAS","Hallak JEC"], journal:"Journal of Psychopharmacology", year:2016, doi:"10.1177/0269881116652578", pmid:"27287824", category:"Reviews", studyType:"Systematic review", openAccess:false, citations:300, abstract:"Comprehensive systematic review of all human studies through 2015 assessing ayahuasca's effects on psychiatric symptoms, neuropsychological functioning, and neuroimaging. Found generally positive safety profile and therapeutic potential.", keywords:["systematic review","psychiatric symptoms","neuropsychological","neuroimaging"], verification:"PubMed" },
  { id:52, title:"Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies", authors:["Dos Santos RG","Osorio FL","Crippa JAS","Riba J","Zuardi AW","Hallak JEC"], journal:"Revista Brasileira de Psiquiatria", year:2016, doi:"10.1590/1516-4446-2015-1701", pmid:"27111702", category:"Reviews", studyType:"Systematic review", openAccess:true, citations:250, abstract:"Systematic review of antidepressive and anxiolytic effects of ayahuasca covering both animal and human studies. Found consistent evidence for acute antidepressant effects.", keywords:["antidepressant","anxiolytic","systematic review","animal studies"], verification:"PubMed" },
  { id:53, title:"Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants", authors:["Romeo B","Karila L","Martelli C","Benyamina A"], journal:"Psychopharmacology", year:2020, doi:"10.1007/s00213-020-05719-1", category:"Reviews", studyType:"Meta-analysis", openAccess:false, citations:120, abstract:"Meta-analysis of classic psychedelics (including ayahuasca) for mood and depressive symptoms. Found significant reductions in depression scores for both clinical and non-clinical populations.", keywords:["meta-analysis","psychedelics","mood disorders","depression"], verification:"DOI" },
  { id:54, title:"Ayahuasca: A review of historical, pharmacological, and therapeutic aspects", authors:["Ruffell SGD","Crosland-Wood M","Palmer R","Netzband N","Tsang WF","Weiss B","Gandy S","Perkins D","Terhune DB","Sarris J"], journal:"Psychiatry and Clinical Neurosciences Reports", year:2023, doi:"10.1002/pcn5.146", pmid:"38868739", category:"Reviews", studyType:"Narrative review", openAccess:true, citations:15, abstract:"Comprehensive review of ayahuasca covering its Amazonian origins, pharmacology of DMT and harmala alkaloids, phenomenological responses, personality and mental health outcomes, and clinical applications. Discusses therapeutic potential while noting the role of shamanic and contextual factors.", keywords:["review","historical","pharmacological","therapeutic"], verification:"PubMed" },
  { id:55, title:"A systematic review on the therapeutic effects of ayahuasca", authors:["Goncalves J","Luis A","Gallardo E","Duarte AP"], journal:"Plants", year:2023, doi:"10.3390/plants12132573", pmid:"37447135", category:"Reviews", studyType:"Systematic review", openAccess:true, citations:20, abstract:"Systematic review of 66 publications on ayahuasca's therapeutic potential covering physical and psychological conditions, antimicrobial properties, and anti-inflammatory effects.", keywords:["systematic review","therapeutic effects","comprehensive"], verification:"PubMed" },
  { id:56, title:"Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016-2020) systematic review of preclinical and human studies", authors:["Dos Santos RG","Hallak JEC"], journal:"Journal of Psychoactive Drugs", year:2021, doi:"10.1080/02791072.2021.1955603", category:"Reviews", studyType:"Systematic review", openAccess:false, citations:40, abstract:"Updated systematic review (2016-2020) of ayahuasca's effects on substance use disorders. Found promising preclinical and observational evidence for anti-addictive properties.", keywords:["substance use disorders","systematic review","addiction","updated"], verification:"DOI" },
  { id:57, title:"Clinical pharmacology of ayahuasca: potential applications and future considerations", authors:["Guerra LTL","da Silva Dias IC","Hallak JEC","dos Santos RG"], journal:"Expert Review of Clinical Pharmacology", year:2025, doi:"10.1080/17512433.2025.2577726", pmid:"41123976", category:"Reviews", studyType:"Narrative review", openAccess:false, citations:5, abstract:"Comprehensive 2025 review of clinical pharmacology of ayahuasca covering therapeutic applications for depression, anxiety, PTSD, and substance use disorders, with discussion of current limitations and future directions.", keywords:["clinical pharmacology","therapeutic applications","future considerations"], verification:"PubMed" },
  { id:58, title:"Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies", authors:["Dos Santos RG","Bouso JC","Hallak JEC"], journal:"Therapeutic Advances in Psychopharmacology", year:2017, doi:"10.1177/2045125316689030", pmid:"28540034", category:"Safety", studyType:"Systematic review", openAccess:true, citations:100, abstract:"Systematic review examining evidence for ayahuasca-related psychotic episodes. Found that most cases involved prior psychiatric history or concurrent substance use. No evidence of persistent psychosis in controlled settings.", keywords:["psychosis","systematic review","safety","psychiatric risk"], verification:"PubMed" },
  { id:59, title:"Therapeutic potential of ayahuasca in grief: a prospective, observational study", authors:["Gonzalez D","Cantillo J","Perez I","Farre M","Feilding A","Obiols JE","Bouso JC"], journal:"Psychopharmacology", year:2020, doi:"10.1007/s00213-019-05446-2", pmid:"31938878", category:"Grief & Trauma", studyType:"Prospective observational", participants:50, openAccess:false, citations:75, abstract:"Prospective study following 50 bereaved individuals through ceremonial ayahuasca. Significant decreases in grief severity at all time points (Cohen's d = 0.84-1.39). Experiential avoidance and decentering mediated improvements.", keywords:["grief","bereavement","prospective","Shipibo ceremony"], verification:"PubMed" },
  { id:60, title:"Potential use of ayahuasca in grief therapy", authors:["Gonzalez D","Carvalho M","Cantillo J","Aixala M","Farre M"], journal:"OMEGA - Journal of Death and Dying", year:2019, doi:"10.1177/0030222817710879", pmid:"28936917", category:"Grief & Trauma", studyType:"Ethnographic / qualitative", openAccess:false, citations:60, abstract:"Qualitative exploration of ayahuasca's potential in grief therapy. Documented emotional confrontations with death, biographical memory review, and symbolic reencounters with the deceased as therapeutic mechanisms.", keywords:["grief therapy","qualitative","death","bereavement"], verification:"PubMed" },
  { id:61, title:"Ayahuasca-assisted meaning reconstruction therapy as an early resource for bereavement: a non-randomized clinical trial", authors:["Soto-Angona O","Sabucedo P","Andion O","Neimeyer RA","Javkin J","Haro JM","Farre M","Gonzalez D"], journal:"Scientific Reports", year:2025, doi:"10.1038/s41598-025-13251-5", pmid:"40890317", category:"Grief & Trauma", studyType:"Open-label trial", participants:84, openAccess:true, citations:5, abstract:"First controlled prospective study of ayahuasca-assisted therapy for grief. 84 participants in meaning reconstruction therapy with or without ayahuasca. Significant improvements in prolonged grief, post-traumatic growth, and quality of life.", keywords:["grief","meaning reconstruction","clinical trial","bereavement"], verification:"Publisher" },
  { id:62, title:"Hypothesis: The psychedelic ayahuasca heals traumatic memories via a sigma 1 receptor-mediated epigenetic-mnemonic process", authors:["Inserra A"], journal:"Frontiers in Pharmacology", year:2018, doi:"10.3389/fphar.2018.00330", pmid:"29686616", category:"PTSD", studyType:"Theoretical / hypothesis", openAccess:true, citations:80, abstract:"Proposes a sigma-1 receptor-mediated mechanism by which ayahuasca may facilitate processing of traumatic memories. Integrates pharmacological, epigenetic, and memory reconsolidation evidence for potential PTSD treatment.", keywords:["PTSD","sigma-1 receptor","epigenetic","traumatic memories","hypothesis"], verification:"PubMed" },
  { id:63, title:"Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use", authors:["Perkins D","Ruffell SGD","Day K","Pinzon Rubiano D","Sarris J"], journal:"Frontiers in Neuroscience", year:2022, doi:"10.3389/fnins.2022.879221", pmid:"36818579", category:"Reviews", studyType:"Narrative review", openAccess:true, citations:45, abstract:"Proposes an integrated model of psychotherapeutic and neurobiological processes underlying ayahuasca's therapeutic effects. Covers emotional processing, memory reconsolidation, neuroplasticity, and the role of setting.", keywords:["therapeutic model","neurobiological","psychotherapeutic","integration"], verification:"PubMed" },
  { id:64, title:"Nourishing the spirit: Exploratory research on ayahuasca experiences along the continuum of recovery from eating disorders", authors:["Lafrance A","Loizaga-Velder A","Fletcher J","Renelli M","Files N","Tupper KW"], journal:"Journal of Psychoactive Drugs", year:2017, doi:"10.1080/02791072.2017.1361559", pmid:"28981401", category:"Psychology", studyType:"Ethnographic / qualitative", participants:16, openAccess:false, citations:80, abstract:"Exploratory qualitative study of 16 participants with eating disorder histories. Found ayahuasca experiences facilitated body awareness, emotional processing, and shifts in self-perception relevant to eating disorder recovery.", keywords:["eating disorders","recovery","body awareness","qualitative"], verification:"PubMed" },
  { id:65, title:"Ceremonial ayahuasca in Amazonian retreats - Mental health and epigenetic outcomes from a six-month naturalistic study", authors:["Ruffell SGD","Netzband N","Tsang W","Davies M","Butler M","Rucker JJH","Tofoli LF","Dempster EL","Young AH","Morgan CJA"], journal:"Frontiers in Psychiatry", year:2021, doi:"10.3389/fpsyt.2021.687615", pmid:"34177670", category:"Psychology", studyType:"Prospective observational", participants:63, openAccess:true, citations:40, abstract:"Six-month prospective study following 63 participants in Amazonian ayahuasca retreats. Found reductions in depression and anxiety persisting at 6 months, with associated changes in DNA methylation of the SIGMAR1 gene (sigma-1 receptor). Epigenetic analysis also examined FKBP5 and BDNF candidate genes.", keywords:["epigenetics","DNA methylation","serotonin transporter","retreat"], verification:"PubMed" },
  { id:66, title:"Preliminary analysis of ayahuasca-induced anatomical alterations in the somatosensory cortex of juvenile non-human primates subjected to chronic stress", authors:["Fernandes Pereira LR","Lira-Bandeira WG","Medeiros-Bandeira AS","Galvao-Coelho NL","Lobao-Soares B"], journal:"Translational Psychiatry", year:2026, doi:"10.1038/s41398-026-03887-w", category:"Neuroscience", studyType:"Preclinical / in vivo", openAccess:true, citations:0, abstract:"Investigates prophylactic effects of ayahuasca on morphological changes in somatosensory cortex induced by chronic stress in juvenile marmosets. Found ayahuasca mitigated stress-induced cortical alterations.", keywords:["non-human primate","somatosensory cortex","chronic stress","neuroprotection"], verification:"Publisher" },
  { id:67, title:"Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and LSD: a systematic review of clinical trials published in the last 25 years", authors:["Dos Santos RG","Osorio FL","Crippa JAS","Riba J","Zuardi AW","Hallak JEC"], journal:"Therapeutic Advances in Psychopharmacology", year:2016, doi:"10.1177/2045125316638008", pmid:"27354908", category:"Reviews", studyType:"Systematic review", openAccess:true, citations:350, abstract:"Systematic review of clinical trials (1990-2015) of ayahuasca, psilocybin, and LSD for depression, anxiety, and addiction. Found beneficial effects for treatment-resistant depression, illness-related anxiety, and substance dependence.", keywords:["systematic review","clinical trials","psychedelics","depression","addiction"], verification:"PubMed" },
  { id:68, title:"Exploring the therapeutic effects of psychedelics administered to military veterans in naturalistic retreat settings", authors:["Calnan M","Blest-Hopley G","Busch C","Adams M","Ruffell SGD","Piper T","Roseman L","Kettner H","Carhart-Harris R"], journal:"Brain and Behavior", year:2025, doi:"10.1002/brb3.70660", pmid:"40619953", category:"PTSD", studyType:"Prospective observational", participants:58, openAccess:true, citations:0, abstract:"First study investigating psychedelic retreats as holistic therapy for veterans' mental health and community reintegration. 58 veterans attended psilocybin or ayahuasca retreats. Significant improvements found for all eight outcomes post-retreat, with greatest improvements for depression (PHQ-9; 29.1%) and PTSD (PCL-5; 26.1%). Ayahuasca retreats demonstrated greater improvements in PTSD scores. Veterans with more severe symptoms benefited most.", keywords:["veterans","PTSD","psilocybin","retreats","military","depression"], verification:"PubMed" },
  { id:70, title:"Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol", authors:["Sabucedo P","Andion O","Neimeyer RA","Soto-Angona O","Javkin J","Haro JM","Farre M","Gonzalez D"], journal:"Frontiers in Psychiatry", year:2025, doi:"10.3389/fpsyt.2024.1484736", pmid:"39839135", category:"Grief & Trauma", studyType:"Clinical trial protocol", openAccess:true, citations:5, abstract:"Protocol for a three-arm non-randomized controlled trial exploring ayahuasca-assisted meaning reconstruction psychotherapy for Prolonged Grief Disorder. Compares A-MR therapy, MR alone, and no treatment in adults experiencing severe grief after loss of a first-degree relative.", keywords:["prolonged grief disorder","protocol","meaning reconstruction","psychotherapy"], verification:"PubMed" },
  { id:71, title:"Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: a randomized controlled trial in healthy subjects", authors:["Aicher HD","Wicki IA","Meling D","Mueller MJ","Dornbierer DA","Scheidegger M"], journal:"Journal of Psychopharmacology", year:2025, doi:"10.1177/02698811251344689", pmid:"40536012", category:"Psychology", studyType:"Randomized controlled trial", openAccess:true, citations:0, abstract:"RCT in healthy subjects showing that a DMT/harmine formulation (ayahuasca analogue) acutely enhances mindfulness and compassion. Findings support the notion that DMT/harmine may have therapeutic potential through enhancing mindfulness and compassion.", keywords:["mindfulness","compassion","DMT","harmine","RCT"], verification:"PubMed" },
  { id:72, title:"Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects", authors:["Aicher HD","Mueller MJ","Dornbierer DA","Suay D","Elsner C","Wicki I","Meling D","Caflisch L","Hempe A","Steinhart C","Mueller J","Von Rotz R","Kleim B","Scheidegger M"], journal:"Frontiers in Psychiatry", year:2024, doi:"10.3389/fpsyt.2023.1302559", pmid:"38264636", category:"Pharmacology", studyType:"Controlled trial", participants:30, openAccess:true, citations:15, abstract:"Controlled study of an ayahuasca-inspired DMT/harmine formulation in healthy subjects. Found rapid and sustained improvements in mood, self-compassion, psychological flexibility, and reductions in stress. Supports therapeutic potential of standardized ayahuasca-analogue formulations.", keywords:["DMT","harmine","formulation","self-compassion","psychological flexibility"], verification:"PubMed" },
  { id:74, title:"Ayahuasca's therapeutic potential: What we know - and what not", authors:["Maia LO","Daldegan-Bueno D","Wiessner I","Araujo DB","Tofoli LF"], journal:"European Neuropsychopharmacology", year:2023, doi:"10.1016/j.euroneuro.2022.10.008", pmid:"36368095", category:"Reviews", studyType:"Narrative review", openAccess:false, citations:80, abstract:"Comprehensive review of ayahuasca's therapeutic effects across clinical conditions. Most consistent evidence for depression and substance use disorders. Growing evidence for grief, eating disorders, PTSD, personality disorders, Parkinson's, Alzheimer's, and serious physical illness. Long-term use shows possible benefits without detrimental effects.", keywords:["therapeutic potential","depression","substance use","neurodegenerative","psychedelics"], verification:"PubMed" },
  { id:75, title:"Human brain effects of DMT assessed via EEG-fMRI", authors:["Timmermann C","Roseman L","Haridas S","Rosas FE","Luan L","Kettner H","Martell J","Erritzoe D","Tagliazucchi E","Pallavicini C","Girn M","Alamia A","Leech R","Nutt DJ","Carhart-Harris RL"], journal:"Proceedings of the National Academy of Sciences", year:2023, doi:"10.1073/pnas.2218949120", pmid:"36940333", category:"Neuroscience", studyType:"Experimental neuroimaging", participants:20, openAccess:true, citations:120, abstract:"First simultaneous EEG-fMRI study of intravenous DMT -- the principal psychoactive compound in ayahuasca -- in humans. Found reduced resting-state network integrity and segregation, increased global functional connectivity, and pronounced changes in default mode, salience, and frontoparietal networks. Results reveal how DMT disrupts canonical brain organization.", keywords:["DMT","EEG-fMRI","default mode network","consciousness","neuroimaging"], verification:"PubMed" },
  { id:76, title:"Shared functional connectome fingerprints following ritualistic ayahuasca intake", authors:["Mallaroni P","Mason NL","Kloft L","Reckweg JT","van Oorsouw K","Toennes SW","Tolle HM","Amico E","Ramaekers JG"], journal:"NeuroImage", year:2024, doi:"10.1016/j.neuroimage.2023.120480", pmid:"38061689", category:"Neuroscience", studyType:"Neuroimaging study", participants:21, openAccess:true, citations:15, abstract:"7T fMRI study of 21 Santo Daime members showing that ayahuasca intake in ritualistic settings reduces connectome idiosyncrasy, producing shared functional fingerprints across participants. Found spatiotemporal reallocation of keypoint edges, with interindividual differences in higher-order connectivity predicting subjective perceptual effects.", keywords:["fMRI","connectome","functional connectivity","ritual","brain networks"], verification:"PubMed" },
  { id:77, title:"Emotion regulation effects of ayahuasca in experienced subjects during implicit aversive stimulation: an fMRI study", authors:["Sanchez TA","Ramos LR","Araujo F","Schenberg EE","Yonamine M","Lobo I","de Araujo DB","Luna LE"], journal:"Journal of Ethnopharmacology", year:2024, doi:"10.1016/j.jep.2023.117430", pmid:"37979818", category:"Neuroscience", studyType:"Experimental fMRI", openAccess:false, citations:8, abstract:"fMRI study in experienced ayahuasca users showing that ayahuasca promotes emotion regulation during aversive stimulation. Found reduced amygdala reactivity and enhanced prefrontal-limbic coupling, with corresponding reductions in anxiety and improved cognition.", keywords:["emotion regulation","fMRI","amygdala","aversive stimuli","cognition"], verification:"PubMed" },
  { id:78, title:"Predicting and exploring ayahuasca effects: perception, mind-wandering, and EEG oscillations", authors:["Silva-Costa N","Pessoa JA","Andrade KC","Mota-Rolim SA","Palhano-Fontes F","Araujo DB","Wiessner I"], journal:"Journal of Psychopharmacology", year:2025, doi:"10.1177/02698811251389563", category:"Neuroscience", studyType:"EEG study", openAccess:false, citations:0, abstract:"EEG study investigating neural mechanisms and predictors of ayahuasca effects. Found changes in perception and mind-wandering correlating with specific EEG oscillation patterns. Baseline neural signatures predicted intensity of subsequent psychedelic experience.", keywords:["EEG","perception","mind-wandering","neural oscillations","predictors"], verification:"DOI" },
  { id:79, title:"Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users", authors:["Fonseca AM","Dos Santos RG","de Medeiros LS","Veiga TAM","Cassas F","Bruniera CP","Rossi GN","Bouso JC","Hallak JEC","Santos FP","Paranhos BAPB","Yonamine M","Rodrigues E"], journal:"European Archives of Psychiatry and Clinical Neuroscience", year:2025, doi:"10.1007/s00406-024-01817-9", pmid:"38780800", category:"Psychology", studyType:"Cross-sectional observational", participants:48, openAccess:false, citations:5, abstract:"Cross-sectional study of 48 participants comparing experienced ayahuasca users (>20 years), beginners (<3 years), and controls. Long-term ritualistic users showed preserved global cognitive function and improved memory performance. No cognitive deficits associated with prolonged ayahuasca use in religious context.", keywords:["cognition","memory","long-term use","ritual users","neuropsychological"], verification:"PubMed" },
  { id:82, title:"Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects", authors:["Rossi GN","Hallak JEC","Ros NM","Santos RG"], journal:"Journal of Clinical Psychopharmacology", year:2021, doi:"10.1097/JCP.0000000000001305", pmid:"33146343", category:"Safety", studyType:"Cross-sectional survey", participants:614, openAccess:false, citations:30, abstract:"Safety evaluation of ritual ayahuasca use among 614 users from a religious institution. Most frequent adverse effects were transient gastrointestinal symptoms. Psychiatric medication use was not associated with increased adverse effects. Institutional safety practices appear sufficient to prevent severe reactions.", keywords:["risk assessment","religious context","adverse effects","safety measures","gastrointestinal"], verification:"PubMed" },
  { id:83, title:"Maternal and developmental toxicity of the hallucinogenic plant-based beverage ayahuasca in rats", authors:["da Motta LG","de Morais JA","Tavares JF","Pic-Taylor A","Caldas ED"], journal:"Reproductive Toxicology", year:2018, doi:"10.1016/j.reprotox.2018.02.010", pmid:"29522798", category:"Safety", studyType:"Preclinical in vivo", openAccess:false, citations:40, abstract:"Rats treated with ayahuasca during gestation at 4X-8X human ritual dose showed mortality, kidney injury, and neuronal loss. At non-lethal doses, enhanced embryolethality and fetal anomalies were observed. Results highlight importance of dose-dependent toxicity and caution during pregnancy.", keywords:["developmental toxicity","pregnancy","teratogenicity","preclinical","dose-response"], verification:"PubMed" },
  { id:84, title:"Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil", authors:["Daldegan-Bueno D","Maia LO","Massarentti CM","Tofoli LF"], journal:"Psychopharmacology", year:2022, doi:"10.1007/s00213-022-06063-2", pmid:"35179623", category:"Addiction", studyType:"Cross-sectional survey", openAccess:false, citations:20, abstract:"Online survey of Brazilian ayahuasca users examining smoking cessation. Users consuming ayahuasca every two weeks or more had 2.16x higher odds of being in the cessation group. Mystical experience during sessions predicted positive outcomes. Process involves repeated rather than single dosing.", keywords:["smoking cessation","tobacco","mystical experience","addiction"], verification:"PubMed" },
  { id:86, title:"Neural network modulation of ayahuasca: a systematic review of human studies", authors:["Santos GHM","Rodrigues LS","Rocha JM","Rossi GN","Ona G","Bouso JC","Hallak JEC","Santos RG"], journal:"Psychoactives", year:2023, doi:"10.3390/psychoactives2010006", category:"Neuroscience", studyType:"Systematic review", openAccess:true, citations:15, abstract:"Systematic review of 11 neuroimaging studies on ayahuasca. Acutely, local neural networks become expanded while overall brain connectivity declines. Default Mode Network modulation is evident. Chronic users show anatomical changes in cingulate cortex. Results indicate a path to short-term neuromodulation.", keywords:["neuroimaging","default mode network","brain connectivity","systematic review","neuromodulation"], verification:"DOI" },
  { id:89, title:"The effects of ayahuasca on psychological disorders: a systematic literature review", authors:["Sheth R","Parikh E","Olayeye K","Pfeifer K","Khanna D"], journal:"Cureus", year:2024, doi:"10.7759/cureus.55574", pmid:"38576633", category:"Reviews", studyType:"Systematic literature review", openAccess:true, citations:10, abstract:"Systematic review covering research from 2017-2023 on ayahuasca for depression, anxiety, substance abuse, eating disorders, and PTSD. Also examines effects on personality traits and the role of mystical experience in therapeutic outcomes. Found consistent evidence for antidepressant and anti-addictive effects.", keywords:["systematic review","depression","anxiety","eating disorders","mystical experience"], verification:"PubMed" },
  { id:90, title:"Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges", authors:["McKenna DJ"], journal:"Pharmacology and Therapeutics", year:2004, doi:"10.1016/j.pharmthera.2004.03.002", pmid:"15163593", category:"Ethnobotany", studyType:"Narrative review", openAccess:false, citations:350, abstract:"Overview of ayahuasca and the regulatory challenges for clinical investigation in the United States. Discusses the UDV biomedical study indicating therapeutic applications for alcoholism and substance abuse. Addresses ill-defined legal status, variable chemical composition, and IND protocol requirements.", keywords:["regulation","clinical investigation","United States","legal status","IND protocol"], verification:"PubMed" },
  { id:91, title:"Safety and side effects of ayahuasca in humans - an overview focusing on developmental toxicology", authors:["Dos Santos RG"], journal:"Expert Opinion on Drug Safety", year:2013, doi:"10.1517/14740338.2013.795148", pmid:"23662333", category:"Safety", studyType:"Narrative review", openAccess:false, citations:90, abstract:"Overview of risks and toxic effects of ayahuasca in humans. Acute administration and long-term consumption do not appear seriously toxic. Limited nonhuman developmental studies suggest possible toxic effects. Data on adolescents exposed in religious contexts are reassuring but more research is needed on pregnant women.", keywords:["developmental toxicology","safety","side effects","pregnancy","adolescents"], verification:"PubMed" },
  { id:92, title:"Meditating on psychedelics: a randomized placebo-controlled study of DMT and harmine in a mindfulness retreat", authors:["Meling D","Egger K","Aicher HD","Jareno Redondo J","Mueller J","Dornbierer J","Temperli E","Vasella EA","Caflisch L","Pfeiffer DJ","Schlomberg JT","Smallridge JW","Dornbierer DA","Scheidegger M"], journal:"Journal of Psychopharmacology", year:2024, doi:"10.1177/02698811241282637", pmid:"39340164", category:"Psychology", studyType:"Randomized placebo-controlled trial", participants:40, openAccess:true, citations:10, abstract:"Randomized placebo-controlled study of DMT and harmine (ayahuasca analogues) during a mindfulness retreat. The combination enhanced meditation depth, mystical experience, and sustained increases in mindfulness compared to placebo. Suggests synergistic effects between psychedelic pharmacology and contemplative practice.", keywords:["mindfulness","meditation","placebo-controlled","DMT","harmine","retreat"], verification:"PubMed" },

  { id:94, title:"EEG gamma coherence and other correlates of subjective reports during ayahuasca experiences", authors:["Don NS","McDonough BE","Moura G","Warren CA","Kawanishi K","Tomita H","Tachibana Y","Bokulich M","Strickland D"], journal:"Journal of Psychoactive Drugs", year:2005, doi:"10.1080/02791072.2005.10399798", pmid:"16149330", category:"Neuroscience", studyType:"EEG study", participants:12, openAccess:false, citations:70, abstract:"QEEG study of ayahuasca experiences showing significant increases in gamma (36-44 Hz) power and coherence during the psychoactive state. Gamma coherence correlated with subjective report intensity. Findings suggest enhanced neural synchrony underlies the ayahuasca experience.", keywords:["EEG","gamma coherence","QEEG","neural synchrony","subjective experience"], verification:"PubMed" },
  { id:95, title:"Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography", authors:["Riba J","Anderer P","Jane F","Saletu B","Barbanoj MJ"], journal:"Neuropsychobiology", year:2004, doi:"10.1159/000077946", pmid:"15179026", category:"Neuroscience", studyType:"EEG-LORETA neuroimaging", participants:18, openAccess:false, citations:140, abstract:"Functional neuroimaging study using LORETA showing ayahuasca activates frontal and paralimbic brain regions. Found increased current density in anterior cingulate and frontal medial cortex. Neurophysiological changes correlated with subjective effects and serotonergic modulation.", keywords:["LORETA","EEG","frontal activation","paralimbic","serotonin"], verification:"PubMed" },
  { id:97, title:"A prospective ecological momentary assessment study of an ayahuasca retreat: exploring the salutary impact of acute psychedelic experiences on subacute affect and mindfulness skills in daily life", authors:["Sznitman SR","Behar YA","Dicker-Oren SD","Shochat T","Meiri D","Butto N","Roe D","Bernstein A"], journal:"Psychopharmacology", year:2025, doi:"10.1007/s00213-024-06704-8", pmid:"39825910", category:"Psychology", studyType:"Prospective ecological momentary assessment", openAccess:true, citations:0, abstract:"Prospective ecological momentary assessment study tracking daily affect and mindfulness around an ayahuasca retreat. Found that acute psychedelic experiences produced sustained improvements in positive affect and mindfulness skills that persisted in daily life over subsequent weeks.", keywords:["ecological momentary assessment","mindfulness","affect","retreat","daily life"], verification:"PubMed" },
  { id:98, title:"Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial", authors:["Dos Santos RG","Osorio FL","Rocha JM","Rossi GN","Bouso JC","Rodrigues LS","de Oliveira Silveira G","Yonamine M","Hallak JEC"], journal:"Journal of Clinical Psychopharmacology", year:2021, doi:"10.1097/JCP.0000000000001428", pmid:"34166299", category:"Clinical Trials", studyType:"Randomized placebo-controlled trial", participants:17, openAccess:false, citations:40, abstract:"First RCT of ayahuasca for social anxiety disorder. 17 volunteers with SAD received ayahuasca or placebo before a simulated public speaking test. Ayahuasca improved self-perception of speech performance without impairing cognitive function. Supports further investigation of ayahuasca for anxiety disorders.", keywords:["social anxiety disorder","speech performance","RCT","placebo-controlled","anxiety"], verification:"PubMed" },
  { id:99, title:"Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers: a pilot, proof-of-concept, randomized controlled trial", authors:["Rocha JM","Rossi GN","de Lima Osorio F","Bouso JC","de Oliveira Silveira G","Yonamine M","Campos AC","Bertozi G","Hallak JEC","Dos Santos RG"], journal:"Journal of Clinical Psychopharmacology", year:2021, doi:"10.1097/JCP.0000000000001396", pmid:"33843820", category:"Clinical Trials", studyType:"Randomized controlled trial", participants:20, openAccess:false, citations:30, abstract:"RCT examining ayahuasca's effects on emotional face recognition in 20 healthy naive volunteers. Ayahuasca reduced recognition of sad and fearful faces while enhancing recognition of happy expressions. Suggests ayahuasca modulates emotional processing biases relevant to depression.", keywords:["facial expressions","emotion recognition","RCT","emotional processing","healthy volunteers"], verification:"PubMed" },
  { id:100, title:"Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: results from two pilot, proof-of-concept, randomized, placebo-controlled trials", authors:["Dos Santos RG","Rocha JM","Rossi GN","Osorio FL","Ona G","Bouso JC","de Oliveira Silveira G","Yonamine M","Marchioni C","Crevelin EJ","Queiroz ME","Crippa JAS","Hallak JEC"], journal:"Human Psychopharmacology", year:2022, doi:"10.1002/hup.2834", pmid:"35107855", category:"Pharmacology", studyType:"Randomized placebo-controlled trial", participants:37, openAccess:false, citations:15, abstract:"Post hoc analysis from two RCTs examining ayahuasca's effects on the endocannabinoid system. In social anxiety disorder volunteers, ayahuasca increased anandamide plasma levels. First evidence linking ayahuasca's therapeutic effects to endocannabinoid modulation.", keywords:["endocannabinoid","anandamide","social anxiety","pharmacology","novel mechanism"], verification:"PubMed" },
  { id:101, title:"Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial", authors:["Mueller MJ","Aicher HD","Dornbierer DA","Marten L","Suay D","Meling D","Elsner C","Wicki IA","Mueller J","Poetzsch SN","Caflisch L","Hempe A","Steinhart CP","Puchkov M","Kost J","Landolt HP","Seifritz E","Quednow BB","Scheidegger M"], journal:"International Journal of Neuropsychopharmacology", year:2024, doi:"10.1093/ijnp/pyaf001", pmid:"39774840", category:"Pharmacology", studyType:"Randomized controlled trial", participants:30, openAccess:true, citations:10, abstract:"First RCT characterizing the pharmacokinetics and pharmacodynamics of a standardized oral DMT/harmine formulation (ayahuasca analogue). Established dose-response relationships for subjective, cardiovascular, and neuroendocrine effects. Enables standardized dosing for future clinical trials.", keywords:["pharmacokinetics","pharmacodynamics","DMT","harmine","standardized formulation","dose-response"], verification:"PubMed" },
  { id:102, title:"Development of a physiologically based pharmacokinetic model of N,N-dimethyltryptamine, harmine, and their interactions from ayahuasca in rats and humans", authors:["Wittayakarn N","Tan YM","Choomalaiwong P","Chen S","Hoer D","Thaoboonruang N","Lohitnavy M"], journal:"Toxicological Sciences", year:2025, doi:"10.1093/toxsci/kfaf118", pmid:"40839168", category:"Pharmacology", studyType:"Pharmacokinetic modeling", openAccess:false, citations:0, abstract:"First physiologically based pharmacokinetic (PBPK) model of DMT and harmine interactions from ayahuasca, developed using rat and human data. Accurately predicts plasma concentration-time profiles and MAO inhibition dynamics. Provides a framework for dose optimization in clinical settings.", keywords:["PBPK model","pharmacokinetics","DMT","harmine","MAO inhibition","dose optimization"], verification:"PubMed" },
  { id:103, title:"Neuroprotective potential of ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease", authors:["Katchborian-Neto A","Santos MFC","Nicacio KJ","Correa JOA","Murgu M","Martins TMM","Gomes DA","Goes AM","Soares MG","Dias DF","Chagas-Paula DA"], journal:"Journal of Ethnopharmacology", year:2020, doi:"10.1016/j.jep.2020.112743", pmid:"32171895", category:"Pharmacology", studyType:"Preclinical in vitro", openAccess:false, citations:75, abstract:"Evaluated neuroprotective potential of ayahuasca and its plant components in a Parkinson's disease cell model using 6-OHDA-induced neurodegeneration. Crude extracts and alkaloid fractions showed neuroprotective effects. Untargeted metabolomics identified beta-carbolines and monoterpene indole alkaloids as key neuroprotective compounds.", keywords:["Parkinson's disease","neuroprotection","metabolomics","6-OHDA","beta-carbolines"], verification:"PubMed" },
  { id:104, title:"The endogenous hallucinogen and trace amine N,N-dimethyltryptamine displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells", authors:["Szabo A","Kovacs A","Riba J","Djurovic S","Rajnavolgyi E","Frecska E"], journal:"Frontiers in Neuroscience", year:2016, doi:"10.3389/fnins.2016.00423", pmid:"27683542", category:"Pharmacology", studyType:"Preclinical in vitro", openAccess:true, citations:200, abstract:"Demonstrated that DMT protects human cortical neurons and microglia-like immune cells against severe hypoxia via sigma-1 receptor activation. Cells pre-treated with DMT showed significantly improved survival under hypoxic stress. Suggests an endogenous protective role for DMT in brain injury.", keywords:["DMT","sigma-1 receptor","hypoxia","neuroprotection","iPSC-derived neurons"], verification:"PubMed" },
  { id:105, title:"Influence of context and setting on the mental health and wellbeing outcomes of ayahuasca drinkers: results of a large international survey", authors:["Perkins D","Schubert V","Simonova H","Tofoli LF","Bouso JC","Horak M","Galvao-Coelho NL","Sarris J"], journal:"Frontiers in Pharmacology", year:2021, doi:"10.3389/fphar.2021.623979", pmid:"33967757", category:"Psychology", studyType:"Cross-sectional survey", participants:6877, openAccess:true, citations:90, abstract:"Analysis of 6,877 ayahuasca drinkers from 40+ countries examining how ceremonial context and setting influence mental health outcomes. Traditional practices, experienced facilitators, and proper preparation were associated with better outcomes. Structural equation modeling identified key mediating variables.", keywords:["set and setting","ceremonial context","mental health","wellbeing","Global Ayahuasca Project"], verification:"PubMed" },
  { id:106, title:"Psychosocial and drug use assessment of regular vs. non-regular ayahuasca users in a Brazilian sample: a web-based survey", authors:["Daldegan-Bueno D","Revesz D","Morais PR","Barbosa PCR","Maia LO"], journal:"Substance Use and Misuse", year:2022, doi:"10.1080/10826084.2022.2063896", pmid:"35466853", category:"Psychology", studyType:"Cross-sectional survey", participants:286, openAccess:false, citations:15, abstract:"Web-based survey comparing regular (n=101) and non-regular (n=185) ceremonial ayahuasca users in Brazil. Regular use was associated with lower anxiety, negative affect, and drug use, plus higher quality of life and intrinsic religiosity. Supports dose-frequency relationship in therapeutic outcomes.", keywords:["regular use","psychosocial","drug use","quality of life","religiosity"], verification:"PubMed" },
  { id:107, title:"A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naive subjects", authors:["Barbosa PCR","Cazorla IM","Giglio JS","Strassman R"], journal:"Revista Brasileira de Psiquiatria", year:2009, doi:"10.1590/S1516-44462009000300006", pmid:"19999673", category:"Psychology", studyType:"Prospective observational", participants:23, openAccess:true, citations:90, abstract:"Six-month prospective study of 23 ayahuasca-naive subjects before and after their first ayahuasca experience in a religious setting. Santo Daime subjects showed reduced psychiatric symptoms and improved mental health. Changes in personality toward more independence and optimism persisted at 6 months.", keywords:["naive subjects","personality","psychiatric symptoms","quality of life","six-month"], verification:"PubMed" },
  { id:108, title:"Ayahuasca, an ancient substance with traditional and contemporary use in neuropsychiatry and neuroscience", authors:["Dos Santos RG","Hallak JEC"], journal:"Epilepsy and Behavior", year:2021, doi:"10.1016/j.yebeh.2019.04.053", pmid:"31182391", category:"Reviews", studyType:"Narrative review", openAccess:false, citations:60, abstract:"Review of ayahuasca's role in neuropsychiatry and neuroscience, covering traditional ceremonial use through modern clinical applications. Discusses evidence for depression, anxiety, addiction, and neurodegenerative conditions. Highlights ayahuasca's unique pharmacological profile and ritual context as factors in therapeutic outcomes.", keywords:["neuropsychiatry","neuroscience","traditional use","contemporary use","review"], verification:"PubMed" },
  { id:109, title:"The therapeutic potentials of ayahuasca: possible effects against various diseases of civilization", authors:["Frecska E","Bokor P","Winkelman M"], journal:"Frontiers in Pharmacology", year:2016, doi:"10.3389/fphar.2016.00035", pmid:"26973523", category:"Reviews", studyType:"Narrative review", openAccess:true, citations:250, abstract:"Proposes that ayahuasca's therapeutic effects are best understood through a bio-psycho-socio-spiritual model. At the biological level, DMT's sigma-1 receptor agonism may counteract chronic low-grade inflammation and oxidative stress underlying diseases of civilization. Integrates pharmacological, psychological, and spiritual dimensions.", keywords:["diseases of civilization","sigma-1 receptor","oxidative stress","inflammation","bio-psycho-socio-spiritual"], verification:"PubMed" },
  { id:110, title:"Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness", authors:["Hamill J","Hallak J","Dursun SM","Baker G"], journal:"Current Neuropharmacology", year:2019, doi:"10.2174/1570159X16666180125095902", pmid:"29366418", category:"Reviews", studyType:"Comprehensive review", openAccess:true, citations:250, abstract:"Comprehensive review of ayahuasca covering behavioral effects, adverse effects, mechanisms of action, and clinical uses in mental illness. Summarizes political/legal factors, electrophysiology, neuroimaging, and pharmacology. Concludes that shamanic wisdom and modern studies converge on therapeutic potential for psychiatric disorders and addictions.", keywords:["comprehensive review","pharmacology","addiction","mental illness","mechanisms of action"], verification:"PubMed" },
  { id:111, title:"Ayahuasca for the treatment of depression", authors:["Palhano-Fontes F","Soares BL","Galvao-Coelho NL","Arcoverde E","Araujo DB"], journal:"Current Topics in Behavioral Neurosciences", year:2022, doi:"10.1007/7854_2021_277", pmid:"34761362", category:"Depression & Mood", studyType:"Book chapter / review", openAccess:false, citations:30, abstract:"Authoritative book chapter reviewing the evidence for ayahuasca as a treatment for depression. Covers the Natal RCT results, neuroimaging findings, biomarker data (BDNF, cortisol, inflammatory markers), and proposed mechanisms of antidepressant action. Discusses challenges of placebo control and standardization.", keywords:["depression","treatment","RCT","mechanisms","book chapter"], verification:"PubMed" },
  { id:112, title:"Assessment of alcohol and tobacco use disorders among religious users of ayahuasca", authors:["Barbosa PCR","Tofoli LF","Bogenschutz MP","Hoy R","Berro LF","Strassman RJ","Barros GS","Lima OSS","Daldegan-Bueno D"], journal:"Frontiers in Psychiatry", year:2018, doi:"10.3389/fpsyt.2018.00136", pmid:"29706907", category:"Addiction", studyType:"Cross-sectional survey", participants:1947, openAccess:true, citations:50, abstract:"Large cross-sectional study of 1,947 religious ayahuasca users assessing alcohol and tobacco use disorders. Ayahuasca users showed significantly lower prevalence of alcohol and tobacco use disorders compared to the general population. Longer duration and higher frequency of ayahuasca use correlated with lower substance use.", keywords:["alcohol use disorder","tobacco use disorder","religious users","prevalence","protective effect"], verification:"PubMed" },
  { id:113, title:"Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca", authors:["Agin-Liebes G","Zeifman R","Luoma JB","Garland EL","Campbell WK","Weiss B","Fogg MS","Watts R"], journal:"Journal of Psychopharmacology", year:2022, doi:"10.1177/02698811221080165", pmid:"35388728", category:"Psychology", studyType:"Prospective observational", participants:50, openAccess:true, citations:30, abstract:"Prospective study examining psychological flexibility and cognitive reappraisal as mechanisms in ceremonial ayahuasca use. Found that increases in psychological flexibility mediated improvements in depression and anxiety symptoms. Cognitive reappraisal played a complementary but distinct therapeutic role.", keywords:["psychological flexibility","cognitive reappraisal","mechanisms","ceremonial use","depression"], verification:"PubMed" },
  { id:114, title:"Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics", authors:["de Vos CMH","Mason NL","Kuypers KPC"], journal:"Frontiers in Psychiatry", year:2021, doi:"10.3389/fpsyt.2021.724606", pmid:"34566723", category:"Reviews", studyType:"Systematic review", openAccess:true, citations:180, abstract:"Systematic review of psychedelics and neuroplasticity covering 16 preclinical and 4 human studies. DMT and ayahuasca stimulate neurogenesis, increase BDNF, and promote dendritic growth. Human studies show BDNF modulation after ayahuasca in depression patients. Neuroplasticity emerges as a key mechanism underlying therapeutic effects.", keywords:["neuroplasticity","BDNF","neurogenesis","dendritic growth","systematic review"], verification:"PubMed" },
  { id:115, title:"Molecular pathways of the therapeutic effects of ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant", authors:["Rossi GN","Guerra LTL","Baker GB","Dursun SM","Saiz JCB","Hallak JEC","Dos Santos RG"], journal:"Biomolecules", year:2022, doi:"10.3390/biom12111618", pmid:"36358968", category:"Pharmacology", studyType:"Narrative review", openAccess:true, citations:35, abstract:"Review of molecular pathways underlying ayahuasca's therapeutic effects. Covers serotonergic, glutamatergic, dopaminergic, and sigma-1 receptor pathways. Discusses anti-inflammatory mechanisms, neuroplasticity via BDNF and mTOR, and endocannabinoid involvement. Positions ayahuasca as a potential rapid-acting antidepressant.", keywords:["molecular pathways","serotonin","glutamate","mTOR","rapid-acting antidepressant"], verification:"PubMed" },
  { id:116, title:"Cortical structural differences following repeated ayahuasca use hold molecular signatures", authors:["Mallaroni P","Mason NL","Kloft L","Reckweg JT","van Oorsouw K","Ramaekers JG"], journal:"Frontiers in Neuroscience", year:2023, doi:"10.3389/fnins.2023.1217079", pmid:"37869513", category:"Neuroscience", studyType:"Neuroimaging study", participants:21, openAccess:true, citations:15, abstract:"7T MRI study of 21 experienced ayahuasca users showing cortical structural differences in regions rich in 5-HT2A receptors. Repeated ayahuasca use was associated with cortical thickness changes in posterior cingulate and precuneus regions. Molecular signature analysis linked structural changes to serotonergic receptor density.", keywords:["cortical thickness","7T MRI","5-HT2A receptors","structural neuroimaging","repeated use"], verification:"PubMed" },
  { id:117, title:"Ayahuasca pretreatment prevents sepsis-induced anxiety-like behavior, neuroinflammation, and oxidative stress, and increases brain-derived neurotrophic factor", authors:["da Silva FS","Silva EAS","Sousa GM","Maia-de-Oliveira JP","Freire FAM","de Almeida RN","Lobao-Soares B","Galvao-Coelho NL"], journal:"Journal of Psychiatric Research", year:2023, doi:"10.1016/j.jpsychires.2023.01.045", pmid:"36764116", category:"Pharmacology", studyType:"Preclinical in vivo", openAccess:false, citations:15, abstract:"Rats pretreated with ayahuasca for 3 days before sepsis induction showed prevention of anxiety-like behavior, reduced neuroinflammation, decreased oxidative stress, and increased BDNF in prefrontal cortex and hippocampus. Demonstrates ayahuasca's neuroprotective and anti-inflammatory properties in an acute stress model.", keywords:["sepsis","neuroinflammation","oxidative stress","BDNF","neuroprotection","preclinical"], verification:"PubMed" },
  { id:118, title:"The current state of ayahuasca research in animal models: a systematic review", authors:["Daldegan-Bueno D","Simionato NM","Favaro VM","Maia LO"], journal:"Progress in Neuro-Psychopharmacology and Biological Psychiatry", year:2023, doi:"10.1016/j.pnpbp.2023.110738", pmid:"36863501", category:"Reviews", studyType:"Systematic review", openAccess:false, citations:25, abstract:"Systematic review of all ayahuasca studies using animal models. Covers behavioral, neurochemical, and toxicological findings. Preclinical evidence supports antidepressant, anxiolytic, and anti-addictive effects. Identifies knowledge gaps including lack of chronic administration studies and need for dose standardization.", keywords:["animal models","preclinical","systematic review","behavioral","neurochemical"], verification:"PubMed" },
  { id:119, title:"Psychedelic therapy: a primer for primary care clinicians - N,N-dimethyltryptamine and ayahuasca", authors:["Shinozuka K","Tabaac BJ","Arenas A","Beutler BD","Cherian K","Evans VD","Fasano C","Muir OS"], journal:"American Journal of Therapeutics", year:2024, doi:"10.1097/MJT.0000000000001725", pmid:"38518268", category:"Reviews", studyType:"Clinical primer / review", openAccess:false, citations:10, abstract:"Clinical primer for primary care physicians on DMT and ayahuasca as emerging therapeutic agents. Covers pharmacology, clinical evidence, safety considerations, and practical guidance for clinicians encountering patients who use or inquire about ayahuasca-based therapies.", keywords:["primary care","clinical primer","DMT","ayahuasca","physician guide"], verification:"PubMed" },
  { id:120, title:"Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members", authors:["Santos RG","Landeira-Fernandez J","Strassman RJ","Motta V","Cruz APM"], journal:"Journal of Ethnopharmacology", year:2007, doi:"10.1016/j.jep.2007.04.012", pmid:"17532158", category:"Psychology", studyType:"Clinical trial", participants:9, openAccess:false, citations:160, abstract:"Clinical trial assessing ayahuasca's acute effects on anxiety, panic, and hopelessness in 9 experienced Santo Daime members. Found significant reductions in panic-like and hopelessness measures without changes in state/trait anxiety. Suggests ayahuasca reduces existential fear rather than general anxiety.", keywords:["anxiety","panic","hopelessness","Santo Daime","acute effects"], verification:"PubMed" },
  { id:121, title:"Ayahuasca: Uses, phytochemical and biological activities", authors:["Estrella-Parra EA","Almanza-Perez JC","Alarcon-Aguilar FJ"], journal:"Natural Products and Bioprospecting", year:2019, doi:"10.1007/s13659-019-0210-5", pmid:"31049844", category:"Reviews", studyType:"Comprehensive review", openAccess:true, citations:80, abstract:"Comprehensive review of ayahuasca covering ethnobotanical origins, chemical composition, pharmacology, and biological activities. Discusses psychoactive effects, traditional therapeutic applications, modern clinical findings, and the multidisciplinary research opportunity ayahuasca represents.", keywords:["phytochemistry","biological activities","ethnobotany","pharmacology","comprehensive review"], verification:"PubMed" },
  { id:122, title:"Psychedelic compounds as a new approach to treating autoimmune conditions", authors:["Flanagan TW","Nichols CD"], journal:"Immunological Investigations", year:2018, doi:"10.1080/08820139.2018.1474169", pmid:"29932779", category:"Pharmacology", studyType:"Review / hypothesis", openAccess:false, citations:95, abstract:"Proposes that psychedelics including DMT and ayahuasca alkaloids may treat autoimmune conditions through potent anti-inflammatory effects mediated by 5-HT2A receptor activation. Reviews evidence that serotonergic psychedelics suppress TNF-alpha, IL-1beta, and other inflammatory cytokines. Suggests a novel therapeutic application.", keywords:["autoimmune","anti-inflammatory","5-HT2A","TNF-alpha","immunomodulation"], verification:"PubMed" },
  { id:123, title:"Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells", authors:["Salles G","de Carvalho Alves I","de Assis Braz G","Barrio Lopes F","dos Santos Fernandes JP","Tamborelli Garcia RC"], journal:"Archives of Toxicology", year:2025, doi:"10.1007/s00204-025-04208-8", category:"Pharmacology", studyType:"Preclinical in vitro", openAccess:false, citations:0, abstract:"Investigated DMT and harmine's neuroprotective effects against cocaine-induced toxicity in human neuroblastoma cells. Both compounds, alone and combined, prevented cocaine-induced apoptosis and maintained cell viability. Supports the mechanistic basis for ayahuasca's anti-addictive properties at the cellular level.", keywords:["cocaine","apoptosis","neuroprotection","DMT","harmine","in vitro"], verification:"DOI" },
  { id:124, title:"Ayahuasca and public health II: health status in a large sample of ayahuasca-ceremony participants from the Netherlands", authors:["Uthaug MV","Mason NL","Toennes SW","Reckweg JT","de Sousa Fernandes Perna EB","Kuypers KPC","van Oorsouw K","Riba J","Ramaekers JG"], journal:"Journal of Psychoactive Drugs", year:2021, doi:"10.1080/02791072.2021.1985055", pmid:"34658340", category:"Safety", studyType:"Cross-sectional survey", participants:377, openAccess:false, citations:20, abstract:"Health status survey of 377 ayahuasca ceremony participants in the Netherlands. Users reported better mental health, lower alcohol consumption, and higher psychological well-being compared to population norms. Few reported lasting adverse effects. Supports the generally positive safety profile in European ceremonial settings.", keywords:["health status","Netherlands","public health","ceremonial","well-being"], verification:"PubMed" },
  { id:125, title:"Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors", authors:["Egger K","Aicher HD","Cumming P","Scheidegger M"], journal:"Cellular and Molecular Life Sciences", year:2024, doi:"10.1007/s00018-024-05353-6", pmid:"39254764", category:"Pharmacology", studyType:"Comprehensive review", openAccess:true, citations:10, abstract:"Comprehensive review of DMT neurobiology from ayahuasca to synthetic MAO inhibitor combinations. Covers receptor pharmacology, neuroimaging, electrophysiology, and clinical data. Discusses the shift from botanical ayahuasca to standardized pharmaceutical-grade DMT/harmine formulations for clinical trials.", keywords:["DMT","MAO inhibition","neurobiological","pharmacology","synthetic formulations"], verification:"PubMed" },
  { id:126, title:"How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy", authors:["Orsolini L","Chiappini S","Papanti D","Latini R","Volpe U","Fornaro M","Tomasetti C","Vellante F","De Berardis D"], journal:"Human Psychopharmacology", year:2020, doi:"10.1002/hup.2728", pmid:"32220028", category:"Reviews", studyType:"Narrative review", openAccess:false, citations:65, abstract:"Reviews ayahuasca from a psychiatric perspective examining evidence for and against entheogenic therapy. Covers antidepressant, anxiolytic, and anti-addictive evidence alongside risks including serotonin syndrome, psychotic episodes, and interactions with psychiatric medications. Balanced assessment of therapeutic promise and clinical caution.", keywords:["psychiatric perspective","entheogenic therapy","pros and cons","serotonin syndrome","clinical caution"], verification:"PubMed" },
  { id:127, title:"Psychedelic-assisted therapy for functional neurological disorder: a theoretical framework and review", authors:["Butler M","Seynaeve M","Nicholson TR","Pick S","Kanaan RAA","Rucker J","Young AH","Ruffell SGD"], journal:"Therapeutic Advances in Psychopharmacology", year:2022, doi:"10.1177/20451253221140631", pmid:"36569784", category:"Reviews", studyType:"Theoretical review", openAccess:true, citations:20, abstract:"Proposes a theoretical framework for psychedelic-assisted therapy (including ayahuasca) for functional neurological disorder (FND). Argues that psychedelics' effects on interoception, predictive processing, and default mode network disruption align with FND pathophysiology. Suggests a novel therapeutic application.", keywords:["functional neurological disorder","predictive processing","interoception","theoretical framework","novel application"], verification:"PubMed" },
  { id:128, title:"Evaluation of the in vitro wound-healing potential of ayahuasca", authors:["Goncalves J","Luis A","Gallardo E","Duarte AP"], journal:"Molecules", year:2022, doi:"10.3390/molecules27185760", pmid:"36144559", category:"Pharmacology", studyType:"Preclinical in vitro", openAccess:true, citations:10, abstract:"First study evaluating ayahuasca's wound-healing potential in vitro. Ayahuasca extracts promoted fibroblast migration and proliferation in scratch wound assays. Anti-inflammatory and antioxidant properties contributed to wound healing. Identifies a novel therapeutic application beyond neuropsychiatry.", keywords:["wound healing","fibroblast","anti-inflammatory","antioxidant","novel application"], verification:"PubMed" },
  { id:129, title:"Immunological modulation and control of parasitaemia by ayahuasca compounds: therapeutic potential for Chagas disease", authors:["Katchborian-Neto A","Santos MFC","Vilas-Boas DF","Dos Santos EG","Veloso MP","Bueno PCP","Caldas IS","Soares MG","Dias DF","Chagas-Paula DA"], journal:"Parasitology Research", year:2023, doi:"10.1007/s00436-023-07884-8", pmid:"37378697", category:"Pharmacology", studyType:"Preclinical in vitro/in vivo", openAccess:false, citations:5, abstract:"Investigated ayahuasca compounds' antiparasitic potential against Trypanosoma cruzi (Chagas disease). Harmine and DMT showed immunomodulatory effects and reduced parasitaemia in animal models. First evidence of ayahuasca alkaloids' anti-parasitic properties, opening a novel therapeutic avenue.", keywords:["Chagas disease","Trypanosoma cruzi","antiparasitic","immunomodulation","harmine"], verification:"PubMed" },
  { id:130, title:"Evaluation of the cytotoxicity of ayahuasca beverages", authors:["Simao AY","Goncalves J","Gradillas A","Garcia A","Restolho J","Fernandez N","Rodilla JM","Barroso M","Duarte AP","Cristovao AC","Gallardo E"], journal:"Molecules", year:2020, doi:"10.3390/molecules25235594", pmid:"33266253", category:"Safety", studyType:"Preclinical in vitro", openAccess:true, citations:20, abstract:"Evaluated cytotoxicity of ayahuasca beverages across multiple cell lines at various concentrations and exposure times. Found dose-dependent cytotoxicity at high concentrations but acceptable cell viability at concentrations equivalent to ceremonial doses. Results support safety at traditional dosing levels.", keywords:["cytotoxicity","cell lines","dose-dependent","safety","ceremonial dose"], verification:"PubMed" },
  { id:132, title:"Exploring psychedelic-assisted therapy for eating disorders: a novel treatment paradigm", authors:["Renelli M","Fletcher J","Tupper KW","Files N","Loizaga-Velder A","Lafrance A"], journal:"Journal of Psychoactive Drugs", year:2020, doi:"10.1080/02791072.2020.1807105", pmid:"32851913", category:"Psychology", studyType:"Mixed methods", participants:16, openAccess:false, citations:45, abstract:"Mixed-methods study of 16 individuals with eating disorder histories who participated in ayahuasca ceremonies. Found significant reductions in eating disorder symptoms and improved body image. Qualitative themes included enhanced body awareness, emotional processing, and spiritual growth. Supports ayahuasca as a novel treatment paradigm for eating disorders.", keywords:["eating disorders","body image","mixed methods","spiritual growth","novel paradigm"], verification:"PubMed" },
  { id:133, title:"Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics", authors:["Chaves C","Dos Santos RG","Dursun SM","Tusconi M","Carta MG","Brietzke E","Hallak JEC"], journal:"Frontiers in Psychiatry", year:2024, doi:"10.3389/fpsyt.2024.1485337", pmid:"39568756", category:"Pharmacology", studyType:"Review", openAccess:true, citations:5, abstract:"Reviews DMT's unique pharmacological features distinguishing it from other classical psychedelics: endogenous production, sigma-1 receptor activity, short duration of action, and neuroplasticity promotion. Discusses implications for therapeutic development including oral (ayahuasca), IV, and intranasal formulations.", keywords:["DMT","unique features","therapeutic potential","sigma-1","endogenous","formulations"], verification:"PubMed" },
  { id:134, title:"Ayahuasca and pain: a systematic review of preclinical studies", authors:["Goncalves J","Luis A","Gallardo E","Duarte AP"], journal:"Psychoactives", year:2025, doi:"10.3390/psychoactives4030024", category:"Reviews", studyType:"Systematic review", openAccess:true, citations:0, abstract:"Systematic review of 29 preclinical studies examining ayahuasca and its alkaloids for pain and inflammation. Found antinociceptive effects of harmine and harmaline involving serotonergic, opioid, and GABAergic systems. Identifies potential mechanisms for pain treatment at central and peripheral levels.", keywords:["pain","antinociceptive","inflammation","harmine","harmaline","preclinical"], verification:"DOI" },
  { id:135, title:"Psychoactive substances of natural origin: toxicological aspects, therapeutic properties and analysis in biological samples", authors:["Goncalves J","Luis A","Gallardo E","Duarte AP"], journal:"Molecules", year:2021, doi:"10.3390/molecules26051397", pmid:"33806501", category:"Pharmacology", studyType:"Comprehensive review", openAccess:true, citations:30, abstract:"Review of natural psychoactive substances including ayahuasca, covering toxicological aspects, therapeutic properties, and analytical methods for biological sample analysis. Discusses DMT and beta-carboline pharmacokinetics, toxicology, and detection in blood and urine.", keywords:["toxicology","analytical methods","biological samples","DMT","beta-carbolines"], verification:"PubMed" },
  { id:136, title:"Ayahuasca: pharmacology, safety, and therapeutic effects", authors:["Dos Santos RG","Hallak JEC"], journal:"CNS Spectrums", year:2024, doi:"10.1017/S109285292400213X", pmid:"39564645", category:"Reviews", studyType:"Comprehensive review", openAccess:false, citations:5, abstract:"Comprehensive 2024 review summarizing ayahuasca pharmacology, safety profile, and therapeutic potential. Notes that few controlled studies exist but available evidence suggests good tolerability and improvements in depression and anxiety symptoms. Calls for larger samples, multiple doses, and longer follow-up periods.", keywords:["pharmacology","safety","therapeutic effects","review","future directions"], verification:"PubMed" },
  { id:138, title:"Acute and subacute effects of ayahuasca on fear of death, wellbeing, and distress tolerance: a controlled study", authors:["Gonzalez D","Cantillo J","Perez I","Llaneza M","Farre M","Feilding A","Obiols JE","Bouso JC"], journal:"Psychopharmacology", year:2023, doi:"10.1007/s00213-023-06385-9", pmid:"37338567", category:"Psychology", studyType:"Controlled study", participants:40, openAccess:false, citations:15, abstract:"Controlled study examining ayahuasca's effects on fear of death, wellbeing, and distress tolerance. Participants showed significant reductions in death anxiety and improvements in wellbeing that persisted at 4-week follow-up. Enhanced distress tolerance correlated with mystical experience intensity.", keywords:["fear of death","wellbeing","distress tolerance","death anxiety","controlled study"], verification:"PubMed" },
  { id:139, title:"Ayahuasca ceremony in the treatment of a patient with PTSD: a case report", authors:["Coelho HF","Oliveira RD","Palhano-Fontes F","de Araujo DB"], journal:"Journal of Psychedelic Studies", year:2021, doi:"10.1556/2054.2021.00185", category:"PTSD", studyType:"Case report", participants:1, openAccess:true, citations:10, abstract:"Detailed case report of a patient with chronic PTSD who participated in ceremonial ayahuasca sessions. Documented significant symptom reduction sustained at 6-month follow-up. Describes the therapeutic process including traumatic memory reprocessing and emotional catharsis during the ayahuasca experience.", keywords:["PTSD","case report","traumatic memory","emotional catharsis","ceremonial"], verification:"DOI" },
  { id:140, title:"Ayahuasca-ceremony network: characterization and comparison of global ayahuasca ceremony offerings", authors:["Kettner H","Rosas FE","Timmermann C","Kartner L","Carhart-Harris RL","Roseman L"], journal:"Frontiers in Pharmacology", year:2021, doi:"10.3389/fphar.2021.623985", pmid:"33995022", category:"Psychology", studyType:"Cross-sectional survey", participants:886, openAccess:true, citations:60, abstract:"Survey of 886 participants across multiple ayahuasca retreat centers examining the psychedelic experience, emotional breakthroughs, and lasting therapeutic effects. Found that emotional breakthrough was the strongest predictor of lasting well-being improvements. Provides a detailed characterization of naturalistic ayahuasca ceremony settings.", keywords:["emotional breakthrough","ceremony","retreat centers","well-being","psychedelic experience"], verification:"PubMed" },
  { id:141, title:"Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine", authors:["Dos Santos RG","Valle M","Bouso JC","Nomdedeu JF","Rodriguez-Espinosa J","McIlhenny EH","Barker SA","Barbanoj MJ","Riba J"], journal:"Journal of Clinical Psychopharmacology", year:2011, doi:"10.1097/JCP.0b013e31823607f6", pmid:"22024613", category:"Pharmacology", studyType:"Comparative study", participants:10, openAccess:false, citations:100, abstract:"Compared autonomic, neuroendocrine, and immunological effects of ayahuasca vs d-amphetamine in 10 healthy volunteers. Ayahuasca increased growth hormone, prolactin, and cortisol (similar to d-amphetamine) but showed unique immunological effects including decreased CD4 and increased NK cells. First comprehensive neuroendocrine-immunological profile.", keywords:["neuroendocrine","immunological","autonomic","d-amphetamine","growth hormone","NK cells"], verification:"PubMed" },
  { id:142, title:"Ayahuasca exposure in early development: effects on brain monoaminergic systems and behavior in juvenile rats", authors:["Pic-Taylor A","da Motta LG","de Morais JA","Junior WM","Santos AF","Campos LA","Mortari MR","Von Zuben MV","Caldas ED"], journal:"Chemical Research in Toxicology", year:2019, doi:"10.1021/acs.chemrestox.9b00246", pmid:"31542915", category:"Safety", studyType:"Preclinical in vivo", openAccess:false, citations:20, abstract:"Examined effects of ayahuasca exposure during early development in rats. Juvenile rats showed alterations in brain monoamine levels (serotonin, dopamine, norepinephrine) and behavioral changes. Higher doses produced anxiogenic effects. Highlights importance of caution regarding ayahuasca use during pregnancy and early development.", keywords:["early development","monoamines","juvenile rats","behavioral","developmental safety"], verification:"PubMed" },
  { id:145, title:"Acute effects of ayahuasca in a juvenile non-human primate model of depression", authors:["da Silva FS","Silva EAS","Sousa GM","Maia-de-Oliveira JP","Soares-Rachetti VP","de Araujo DB","Lobao-Soares B","Galvao-Coelho NL"], journal:"Behavioural Brain Research", year:2019, doi:"10.1016/j.bbr.2018.10.010", pmid:"30316860", category:"Depression & Mood", studyType:"Preclinical in vivo", openAccess:false, citations:40, abstract:"Investigated acute antidepressant effects of ayahuasca in juvenile marmosets subjected to social isolation (depression model). Ayahuasca reversed depressive-like behaviors including anhedonia and reduced cortisol levels. First study demonstrating ayahuasca's antidepressant potential in a non-human primate model.", keywords:["non-human primate","marmoset","depression model","antidepressant","cortisol"], verification:"PubMed" },
  { id:146, title:"Ayahuasca's biological action on the serotonergic system: therapeutic perspectives", authors:["Dominguez-Clave E","Soler J","Elices M","Pascual JC","Alvarez E","de la Fuente Revenga M","Friedlander P","Feilding A","Riba J"], journal:"Frontiers in Pharmacology", year:2022, doi:"10.3389/fphar.2022.1001402", category:"Pharmacology", studyType:"Narrative review", openAccess:true, citations:20, abstract:"Reviews ayahuasca's mechanisms via the serotonergic system. Covers 5-HT2A agonism by DMT, 5-HT reuptake inhibition by THH, MAO-A inhibition by harmine and harmaline, and downstream effects on neuroplasticity and emotional processing. Discusses how serotonergic modulation underlies therapeutic applications for mood disorders.", keywords:["serotonergic system","5-HT2A","MAO-A","THH","mood disorders","mechanisms"], verification:"DOI" },
  { id:147, title:"Ayahuasca microdosing: a systematic review of practices, safety and reported outcomes", authors:["Ona G","Bouso JC"], journal:"Journal of Psychoactive Drugs", year:2023, doi:"10.1080/02791072.2022.2141990", pmid:"36385710", category:"Reviews", studyType:"Systematic review", openAccess:false, citations:15, abstract:"First systematic review of ayahuasca microdosing practices and outcomes. Found limited but growing evidence for sub-perceptual dosing. Users reported improved mood, focus, and creativity. Safety data are scarce. Distinguishes microdosing from full ceremonial doses and identifies key research gaps.", keywords:["microdosing","sub-perceptual","systematic review","safety","mood","creativity"], verification:"PubMed" },
  { id:148, title:"Examining the therapeutic effect of ceremonial ayahuasca on narcissistic personality and antagonistic externalizing in adults", authors:["Weiss B","Sleep C","Miller JD","Campbell WK"], journal:"Journal of Personality Disorders", year:2023, doi:"10.1521/pedi.2023.37.2.131", pmid:"37002934", category:"Psychology", studyType:"Prospective observational", participants:314, openAccess:true, citations:20, abstract:"First prospective study examining psychedelics and narcissism. 314 adults assessed at baseline, post-retreat, and 3-month follow-up using self- and informant-report (N=110). Self-reported decreases in NPI Entitlement-Exploitativeness and a proxy measure of NPD were observed, but effect sizes were small and no significant changes were detected by informants. Provides modest support for adaptive change in narcissistic antagonism.", keywords:["narcissism","personality disorders","entitlement","antagonism","ego dissolution","ceremonial"], verification:"PubMed" },
  { id:149, title:"The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience", authors:["Shanon B"], journal:"Oxford University Press", year:2002, doi:"10.1093/oso/9780199252923.001.0001", category:"Psychology", studyType:"Academic book", openAccess:false, citations:900, abstract:"Pioneering cognitive-psychological study of the ayahuasca experience. Based on the author's extensive personal experiences and interviews with hundreds of informants  indigenous people, shamans, religious sect members, and travelers. Provides the most comprehensive phenomenological mapping of the ayahuasca state of consciousness, including visions, altered temporality, synesthesia, and noetic feelings. Lays theoretical foundations for studying non-ordinary states of consciousness.", keywords:["phenomenology","cognition","visions","consciousness","cognitive psychology","book"], verification:"Publisher" },
  { id:150, title:"Ayahuasca visualizations: A structural typology", authors:["Shanon B"], journal:"Journal of Consciousness Studies", year:2002, doi:"", category:"Psychology", studyType:"Phenomenological analysis", openAccess:false, citations:120, abstract:"Examines the structural forms of ayahuasca-induced visualizations from a cognitive-psychological perspective. Draws a typology of visual experiences including geometric patterns, scenes, beings, and landscapes. Analyzes the interaction between observer and vision, the semantics of visions, and their narrative structure. Applicable to hallucinatory experiences from other agents.", keywords:["visualizations","typology","phenomenology","visions","cognitive psychology"], verification:"Publisher" },
  { id:151, title:"Altered states and the study of consciousness: The case of ayahuasca", authors:["Shanon B"], journal:"Journal of Mind and Behavior", year:2003, doi:"", category:"Psychology", studyType:"Theoretical/hypothesis", openAccess:false, citations:80, abstract:"Discusses ayahuasca-induced altered states as data for a theory of consciousness. Proposes consciousness as a cognitive system defined by parameters whose values can be modified by ayahuasca. Following William James and Aldous Huxley, argues that any general theory of consciousness must incorporate non-ordinary states alongside ordinary experience.", keywords:["consciousness","altered states","cognitive system","parameters","theory"], verification:"Publisher" },
  { id:152, title:"The epistemics of ayahuasca visions", authors:["Shanon B"], journal:"Phenomenology and the Cognitive Sciences", year:2010, doi:"10.1007/s11097-010-9161-3", category:"Psychology", studyType:"Philosophical analysis", openAccess:false, citations:60, abstract:"Examines the epistemic status, meaning, and interpretation of substance-induced visions, focusing on ayahuasca. Under the intoxication, people report gaining significant knowledge and understanding  psychological insights, philosophical ideations, and spiritual experiences. Takes a cognitive-phenomenological perspective coupled with philosophical epistemological analysis.", keywords:["epistemics","visions","knowledge","phenomenology","philosophy of mind"], verification:"DOI" },
  { id:153, title:"Biblical entheogens: A speculative hypothesis", authors:["Shanon B"], journal:"Time and Mind", year:2008, doi:"10.2752/175169608783489116", category:"Ethnobotany", studyType:"Theoretical/hypothesis", openAccess:false, citations:70, abstract:"Proposes that ancient Israelite religion was associated with the use of entheogens. Based on the observation that DMT-containing Acacia species and MAO-inhibiting Peganum harmala  pharmacologically equivalent to ayahuasca components  grow in the Sinai and southern Israel. Draws parallels between ayahuasca phenomenology and biblical accounts of Moses' experiences, corroborated by linguistic, ethnobotanical, and exegetical data.", keywords:["entheogens","biblical","Moses","Acacia","Peganum harmala","Sinai"], verification:"DOI" },
  { id:154, title:"The Therapeutic Use of Ayahuasca", authors:["Labate BC","Cavnar C"], journal:"Springer", year:2014, doi:"10.1007/978-3-642-40426-9", category:"Reviews", studyType:"Edited academic book", openAccess:false, citations:350, abstract:"First systematic collection on the therapeutic potential of ayahuasca. Presents biomedical and anthropological perspectives on its use for depression, PTSD, and substance dependence across indigenous, neo-shamanic, therapeutic, and religious settings. Contributors include Winkelman, Palhano-Fontes, Nielson, Loizaga-Velder, Strassman, and Mat. Stimulates discussion on methodological, ethical, and political aspects of ayahuasca research.", keywords:["therapeutic","edited volume","depression","PTSD","substance dependence","book"], verification:"DOI" },
  { id:155, title:"Ayahuasca Healing and Science", authors:["Labate BC","Cavnar C"], journal:"Springer", year:2021, doi:"10.1007/978-3-030-55688-4", category:"Reviews", studyType:"Edited academic book", openAccess:false, citations:80, abstract:"Updated collection on ayahuasca healing integrating the latest scientific findings. Covers childhood trauma, harm reduction, Canadian drug policy, eating disorders, and neurobiological mechanisms. Includes contributions by Nielson, Mason, Kuypers, Argento, Lafrance, and others. Bridges traditional knowledge and contemporary clinical science.", keywords:["healing","science","edited volume","harm reduction","childhood trauma","book"], verification:"DOI" },
  { id:156, title:"DMT: The Spirit Molecule  A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences", authors:["Strassman R"], journal:"Park Street Press", year:2001, doi:"", category:"Pharmacology", studyType:"Academic book", openAccess:false, citations:1500, abstract:"Groundbreaking account of the first DEA-approved clinical research on DMT in over 20 years. Documents dose-response studies in 60 volunteers at the University of New Mexico, describing the phenomenology of IV DMT experiences including near-death, mystical, and entity-contact states. Proposes the pineal gland hypothesis for endogenous DMT. Essential foundational text for understanding the pharmacological basis of the ayahuasca experience.", keywords:["DMT","clinical research","mystical experience","near-death","pineal gland","book"], verification:"Publisher" },
];

export default VERIFIED_ARTICLES;
